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The aim of this project is to identify behavioural phenotypes associated with ethanol in C. 
elegans and potential molecular targets for ethanol that underpin an ethanol response. This will 
be achieved through a multi-lateral approach using bioinformatics, genetics and neuroscience 
based methodology.  
  In accord with previous experiments, behavioural analysis showed that several phenotypes 
could be used to describe and assess the state of ethanol induced intoxication and dependence 
over a range of concentrations. C. elegans exhibits an inhibition of locomotion at high ethanol 
concentrations. This manifests as a reduction in the population that chemotax towards a food 
reward whilst lower ethanol concentrations show no such reduction in population chemotaxis. 
There is also a change in locomotion which characterises an ethanol withdrawal; this is a 
separate response from the intoxicating behaviour seen at higher concentrations. Similar to the 
response seen in populations, individual worms show a dose dependent reduction in pharyngeal 
pumping rate. This also shows no significant difference at lower concentrations to their 
untreated counterparts. 
  Observations from studying pharyngeal pumping indicate that worms do show a behavioural 
response at lower ethanol concentrations. Worms placed in an environment with food and 
ethanol will not exhibit feeding behaviour as control worms do, instead worms disperse away 
from the food source. This behaviour can be observed at a threshold of around 10mM ethanol. It 
is unclear how ethanol causes this phenotype. Overall, these data provides new paradigms for 
assessing low dose effects. These assays will be important for future studies designed to model 
low dose effects. 
  With respect to higher doses, ethanol is known to activate cellular and physiological pathways 
that underpin stress. Here, we have investigated whether the unfolded protein response (UPR) is 
an important mediator of stress induced by ethanol. Our evidence suggests no clear activation of 
the UPR by ethanol concentrations that exert behavioural effects. In an attempt to pre-empt 
genetic data, we initiated a database of genes involved in ethanol responses, which were mapped 
on to C. elegans and human homologues. These were used to build an ethanol network, which 
could be used to refine investigations of ethanol-related genes in C. elegans. ii 
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1  Introduction 
1.1  Ethanol toxicity, metabolism and distribution 
Ethanol is a 2 carbon, aliphatic molecule with a hydroxyl group. It is the active ingredient in 
alcoholic beverages consumed globally. It comes from the natural product of anaerobic 
fermentation by the yeast Saccharomyces cerevisiae and has been utilised by humans 
throughout recorded history. Such is the popularity of ethanol as a social beverage that in 2006 
the total UK household expenditure on alcohol totalled approximately £41.6bn. This is greater 
than the entire UK national defence budget for 2010/11. The consumption of alcohol is not risk 
free and comes with a considerable health risk depending on the duration and amount 
consumed. In the UK, as of 2004, the cost to the National Health Service (NHS) is estimated to 
be between £1.4 billion and £1.7 billion a year. The estimated cost of alcohol-related crime and 
anti-social behaviour estimated to be up to £7.3 billion per year (NHS Information centre, 
2008). The health costs also translate into private sector economic losses, with up to an 
estimated £6.4 billion lost through alcohol related loss of productivity (UK Cabinet Office, 
2004). Thus ethanol is a considerable cause of mortality and morbidity with vast economic cost. 
Ethanol is a wide-acting, low specificity central nervous system (CNS) depressant. The acute 
effects of ethanol range from stimulation and euphoria at low doses through to relaxation and 
sedation at moderate to high doses. At higher doses ethanol acts as an anaesthetic, which can 
depress the CNS to such an extent as to lead to coma and cessation of respiratory function. 
Further complicating the risks associated with acute intoxication, chronic consumption can also 
lead to severe health problems dependent on the drinking pattern. Ethanol has both positive, 
reward, and negative, relief from, reinforcing affects which can lead to psychological and 
physiological dependence. Physiological dependence is associated with additional medical 
complications to those associated with acute and chronic intoxication. Withdrawal from 
dependence can result in convulsions, coma and death; it is commonly treated by drugs with 
similar sites of action to alcohol, such as benzodiazepines (Schuckit, 2009). 
1.2  Ethanol metabolism  
Approximately 95% of ethanol is metabolized by the body, with the remainder passed out in the 
breath, sweat and urine. In humans, alcohol is metabolized by a rate of 10 g/hour (Zakhari, 
2006). Ethanol is metabolised by the enzyme alcohol dehydrogenase, which is predominantly 
found in the liver but is expressed throughout the body. Ethanol is metabolised into 
acetaldehyde and then to acetic acid by the enzyme acetaldehyde dehydrogenase. Acetaldehyde 
is an unstable product and can form free radicals under cellular conditions. Some of the effects 
of ethanol intoxication and withdrawal are believed to be due to acetaldehyde formation 2 
 
(D'Addario et al., 2008), although this theory remains controversial due to the low levels of 
serum acetaldehyde and the difficulty of it crossing the blood brain barrier. Acetic acid can 
either be directly excreted in the urine or converted to acetyl Co-enzyme A by the enzyme 
ACSS2, where it can be further metabolised in the Krebs cycle. Ethanol is also metabolized by 
catalase and cytochrome P450 2E1, although the extent to which these two enzymes play a role 
in vivo is unclear; these enzymes are thought to act when ethanol levels are high or in regions 
with low alcohol dehydrogenase activity, such as in the central nervous system.  
1.3  Ethanol distribution 
Ethanol quickly diffuses through the body showing no major localisation at any one organ 
(Gifford et al., 2008). Molecular interaction simulations and NMR studies show that ethanol 
resides in the phosphate backbone of the lipid bilayer (Chanda and Bandyopadhyay 2004, 
Gurtovenko and Anwar 2009). Blood alcohol levels are indicative of brain alcohol levels. The 
liver is the main organ associated with ethanol metabolism and therefore is considerably 
damaged after chronic ethanol drinking. Alcoholic fatty liver disease, alcoholic hepatitis and 
cirrhosis are often the outcomes of chronic ethanol abuse. Away from the liver several organs 
suffer from the abuse of chronic ethanol consumption. The gastric system is at a higher risk of 
developing cancer on ethanol abuse. The heart may suffer with alcoholic cardiomyopathy and a 
higher risk of atherosclerosis. Excessive alcohol consumption is also a risk factor for type 2 
diabetes. Fertility is also reduced with chronic ethanol consumption.  
In the brain chronic ethanol abuse can result in Wernicke’s encephalopathy and Korsakoff’s 
syndrome. Two conditions associated with poor motor coordination, ataxia, short term memory 
loss and confusion. Sufferers often have overlapping symptoms and illness is sometimes 
classified as Wernicke-Korsakoff syndrome. The brain may also suffer atrophy of the prefrontal 
cortex in alcoholics. 
Ethanol when ingested contributes to a huge range of health problems dependent on the 
concentration of ethanol and the length of time it is consumed over. The wide scope of ethanol’s 
actions is apparent in the distribution of health problems over the body. These are underwritten 
by a large number of molecules that ethanol is thought to interact with. As with many drugs that 
work to affect the CNS, ethanol controls a varying degree of behaviours. These too are 
controlled by the many molecules that ethanol interacts with in a time and dose dependent 
fashion. 
1.4  Molecular targets of ethanol in C. elegans 
1.4.1  SLO-1 
SLO-1 is a BK (“Big K
+ conductance”) calcium activated potassium channel (CAK) activated 
by increases in intracellular calcium concentration or membrane depolarisation. The role of 3 
 
CAKs is as action potential inhibitors through reducing cell excitability via hyperpolarisation. 
SLO-1 tends to be found at neuron-smooth muscle junctions at both the presynaptic and post 
synaptic terminals (Holden-Dye et al., 2007). C. elegans SLO-1 has been shown to be activated 
by ethanol between 20-100mM. slo-1 mutants are resistant to ethanol and slo-1 gain of function 
mutants resemble ethanol intoxicated worms (Davies et al. 2003). Ethanol has been shown to 
inhibit the frequency of body bends, locomotion speed and egg laying, of which locomotion 
speed and egg laying defects are absent in slo-1 mutants. Changes in ethanol resistance were 
independent of membrane permeability and ethanol metabolism. The effects of ethanol 
resistance were not due to hyperactivity caused by loss of slo-1 as confirmed by mutant 
comparison and aldicarb resistance. In general, acute ethanol activates the SLO-1 channel and 
depresses neuron firing.  
Chronic ethanol consumption affects the SLO-1 channel by reducing sensitivity to ethanol, 
increasing SLO-1 expression and reducing the number of channels at the cell membrane. 
Alternatively, increased slo-1 expression has been linked to an increase in positive acting cAMP 
response element-binding protein isoforms (CREB), inducing expression of slo-1 on ethanol 
exposure. These changes may underlie the compensatory changes made in ethanol tolerance as a 
result of chronic consumption. Underlying these changes may also be a role of membrane lipids 
and accessory proteins (Yuan et al., 2000). Indeed the membrane lipid raft hypothesis has 
become a popular theory for describing the action of alcohol on certain membrane components, 
and there is certainly evidence for a role of lipid and ethanol structural content in the membrane 
affecting membrane proteins.  
1.4.2  GAS-1 
GAS-1 is a 49-kDa subunit of complex I of the mitochondrial electron transport chain in C. 
elegans. Mutations in the gas-1 gene increase sensitivity to ethanol. Complex I is required for 
the first steps of oxidative phosphorylation; the transfer of an electron from NADH to a 
quinone. The 49kDa GAS-1 subunit is conserved between species and required for complete 
complex I subunit assembly and function. Complex I is the mitochondrial electron transport 
chain component most sensitive to ethanol and volatile anaesthetics. Measuring the levels of 
oxidative phosphorylation in wild-type and gas-1 mutants Kayser et al. concluded that 
sensitivity arose solely from complex I inhibition. Sensitivity of gas-1 mutants to ethanol is 
specifically because of the reduced rate of complex I activity (Kayser et al., 2003). The authors 
suggest that ethanol may affect movement because of the reduced output of ATP. It is also 
worth noting that the authors raise concerns about the potential difference in mitochondrial 
diffusion rates and site specific ethanol concentration when extrapolating from in vitro to in 
vivo. Previous work by the group has also linked gas-2 and unc-79 with ethanol sensitivity and 
locomotion (Morgan and Sedensky, 1995). 4 
 
1.4.3  NPR-1 
npr-1 encodes a putative neuropeptide Y family, GPCR protein which binds the ligands of two 
FMRFamide-related peptides. npr-1 has been shown to alter the behaviours of locomotion, 
social aggregation and food bordering (de Bono et al. 2002, Gloria-Soria and Azevedo 2008, 
Harvey 2009). The wild C. elegans strain CB4856 has a single point mutation, V215F, which 
results in a lower function allele of which no other isotypes have been found to exist in other 
natural populations. Ethanol acts as a depressant of locomotion in worms; but has less of an 
affect over time due to the development of tolerance. The CB4856 strain develops ethanol 
tolerance more rapidly than N2 independent of initial response, locomotory speed or metabolic 
clearance. This difference in tolerance maps to the npr-1 locus (Davies et al., 2004). NPR-1 
plays a role in negatively regulating the development of acute tolerance. Evidence suggests that 
the suppression of food dependent social behaviours by NPR-1 and the suppression of acute 
ethanol tolerance are separable affects and are likely to work through separate pathways. It is 
believed that the two ligands of NPR-1, Flp-18 and Flp-21 may play a role in NPR-1 mediated 
tolerance, although Flp-21 mutants showed no difference from N2 and Flp-18 has yet to be 
analysed. The evidence suggests that ethanol increases NPR-1 activity, thus resulting in a down 
regulation of this pathway in a plastic response to exposure, with withdrawal from ethanol then 
leaving this down regulation exposed to normal conditions (Davies et al., 2004).  
1.4.4  Exocytosis and the SNARE complex  
Exocytosis of neurotransmitters from the presynaptic nerve requires vesicle fusion and release 
of pre-stored transmitters. This is achieved via the SNARE complex, which consists of three 
main proteins SNAP-25, VAMP-2 and syntaxin-1. Munc18-1 is a murine SM family protein 
that associates with syntaxin-1 to assist in vesicle transport, vesicle docking and syntaxin-1 
transport (Deak et al. 2009, Rodkey et al. 2008). Munc18-1 associates with the SNARE 
complex protein syntaxin-1 and controls sensitivity to ethanol. A D216N mutation in the protein 
regulates ethanol preference, and appears to modulate SNARE complex binding by Munc18-1. 
The mutation broadens the duration of single exocytotic events. An orthologous mutation in C. 
elegans unc-18 also confers resistance to ethanol (Graham et al., 2009). 
There is no obvious defect in the synaptic machinery in the C. elegans mutants, although it does 
seem that the mutation may increase synaptic output. This would possibly indicate that ethanol 
would work to reduce synaptic transmission and that mutations that affect the exocytotic output 
may confer resistance to alcohol. This correlates well with evidence that resistance to the acute 
effects of ethanol is a risk factor for alcoholism. Alterations to the vesicle fusion process and 
resistance to ethanol have also been recently noted in studies looking at the proteins RAB3 and 
AEX3, which control vesicle docking and fusion (Kapfhamer et al., 2008). This implicates 
ethanol in the wider machinery of synaptic output as a mechanism for the acute effects of 
intoxication and the development of alcoholism.  5 
 
1.4.5  Heat shock proteins and chaperones 
Mutagenesis screens identified four genes that conferred resistance to the anaesthetic affects to 
ethanol (Hong et al., 2008). These genes were jud-1 to jud-4 and remain poorly characterised. 
jud-4 is C02D4.1 which shares limited homology with the mammalian Homer proteins. jud-4 is 
not expressed neuronally but in the hypodermis and vulva muscles. It is not clear how these 
genes interact with ethanol or the biological system to bring about changes in sensitivity to 
anaesthetics (Hong et al., 2008). Earlier work by the same group have also looked at a large 
scale genomics approach to the actions of ethanol, and characterised what appears to be an 
induction of the unfolded protein response. They characterised genes that may be affected by 
ethanol exposure at different time points using Microarray analysis. 
Of interest was that ethanol induced a lot of heat shock genes and two non-chaperone genes, glr-
2 and T28C12.4 a protein with limited homology to human neuroligin. As we see later on GLR 
may require the unfolded protein response (UPR) equipment for specialised folding, and an 
upregulation may indicate that transport is perturbed (Shim et al., 2004). The group used an 
ethanol concentration of 7% v/v in M9 buffer. They found that the 230 non-redundant genes 
were differentially expressed.  They identified a region upstream of several genes involved in 
the stress response which they named the ESRE (ethanol and stress dependent response 
element). This sequence was conserved between C. briggsae and C. elegans (Kwon et al., 
2004). It has functional overlap with regulatory elements described by another group 
(GuhaThakurta et al., 2004). They later went on to show the difference in regulatory sequences 
of different aspects of the heat shock proteins on various stresses including ethanol (Hong et al., 
2004). This evidence offers a large support to the idea that ethanol stress is a trigger for the 
UPR. 
1.4.6  CREB 
cAMP response element binding protein (CREB) is a downstream bZIP transcription factor with 
two isoforms alpha and delta. It has a common KID domain with a serine residue at position 133 
which gets phosphorylated. Phosphorylation of serine 133 allows binding of CREB to the CRE 
region in the promoters of 100+ genes (Suo et al., 2006). It is predominantly associated with 
activation of upstream metabotropic receptors and changes in calcium or cAMP dependent 
signalling. It holds a significant interest with relation to this project because of its homology to 
the ATF proteins activated on the UPR, its role in ethanol mediated neurodegeneration and its 
possible activation by NPR-1 and the link to ethanol mediated tolerance (Davies et al., 2004).  
Glutamate receptor mediated excitotoxicity and oxidative stress are two of the prevalent 
mechanisms associated with neurodegeneration. The underlying toxicity of these factors is 
mediated by the antagonistic actions of the transcription factors CREB and NF-κB. These two 
transcription factors mediate toxicity by antagonistically binding DNA. This can be 
demonstrated with drugs that either increase CREB binding to DNA, and thus dampen toxicity, 6 
 
or decrease CREB binding to DNA and increase toxicity. Ethanol decreases CREB levels and 
increases levels of NF-κB DNA-binding activity, thus increasing neurotoxicity (Zou and Crews, 
2006).   
Rat based binge drinking models of ethanol consumption result in neurodegeneration in selected 
brain regions. Both CREB and NPY are diminished in the hippocampal dentate gyrus during 
binge drinking but increase on ethanol withdrawal. The expression of these two proteins is 
negatively correlated with neurodegeneration, which is more prevalent after 4 days of binge 
drinking. Neurogenesis may be controlled by CREB and this is shown to be decreased during 
binge drinking whilst increasing after sustained abstinence (Pandey et al., 2005a).  
Increased anxiety is often seen as a risk factor for the development of alcohol abuse. 
Withdrawal after chronic exposure decreases phosphorylated (activated) CREB and NPY in 
different regions. This process in the central amygdala may be linked to ethanol withdrawal 
mediated anxious behaviour. Administration of a PKA inhibitor into the central amygdala 
reduces phosphorylated CREB levels and increases anxious behaviour and ethanol preference. 
CREB levels are lower in preferring rats vs. non-preferring. CREB may mediate anxiety and 
alcohol preference via NPY modulation (Pandey et al., 2005b). Therefore CREB may act as a 
genetic determinant of alcohol abuse. CREB has also been shown to help mediate the effects of 
self-administration of several drugs of abuse. Ethanol increases the levels of phosphorylated 
CREB in the nucleus accumbens; promoting self-administration. This may be due to an increase 
in striatial proenkephalin (Newton and Messing, 2006).  
In C. elegans CREB plays an important role in synaptic plasticity and starvation. The protein 
CREB maps to the C .elegans homolog CRH-1. CRH-1 is activated in a subset of neurones, the 
SIA neurons, on starvation. This is mediated by the GPCRs ser-3 and egl-30. It is partially 
dependent on phospholipase C and is negatively regulated by GOA-1 and calcium/calmodulin 
dependent kinase (CMK-1) (Suo et al., 2006). CRH-1 also controls foraging rate in C. elegans. 
CRH-1 modulates tph-1 expression in the ADF neurons, whose post-synaptic effects are 
controlled by the (5-HT2-like) SER-1 receptors. The serotonergic circuit is also contributed to 
by the interneuron RIH which lacks any expression of tph-1. The RIH serotonergic phenotype 
relies solely on exogenous sources of neurotransmitter, through the ADF neurons. CRH-1 drives 
expression of tph-1 which controls 5HT metabolism. 5HT is responsible for negatively 
regulating foraging rate through SER1 and SER4 (Zubenko et al., 2009). These two results 
would seem at odds because Suo et al. suggest that starvation induces CREB whilst Zubenko et 
al. suggest that this would reduce foraging rate. Clearly the picture is more complicated and 
needs to be reconciled. But it does suggest a role for tph-1 and crh-1 in starvation induced 
behaviour.  7 
 
1.4.7  GABA 
Gamma-aminobutyric acid (GABA) is an inhibitory neurotransmitter which binds to two sub 
sets of receptor, ionotropic receptors GABAA and GABAC (chloride pore forming) and 
metabotropic receptors GABAB (G-protein coupled). GABA is synthesised in the cytoplasm 
from glutamate by the enzyme L-glutamic acid decarboxylase (GAD) using PLP as a co-factor. 
The effects of ethanol have been primarily noted in the GABAA and GABAB receptors (Federici 
et al., 2009; Werner et al., 2009). GABAA receptor is a chloride pore composed of 5 of the 19 
available protein isoforms (ʱ1-6, β1-3, γ1-3, δ, ε, θ, π, ρ). These combinations would result in a 
large number of receptor subtypes if all associations were independent, but this is not the case 
and many of the subunits associate only with others. 
Each subunit consists of a large, extracellular, N-terminal, cysteine loop containing domain 
attached to four transmembrane domains and a short extracellular C-terminus. A combination of 
the protein subunits 2nd trans-membrane regions associate to make up the lumen of the chloride 
pore. This central chloride pore is involved in the influx of chloride ions into the cell or 
resulting in hyperpolarisation. The predominant forms of GABAA receptor subtypes found in 
the mammalian brain are the 2ʱ12β2γ2 subtype making up 60%, the 2ʱ22β3γ2 subtype at 15% 
and the 2ʱ32β3γ2 subtype at 10% (Michels and Moss, 2007). The various other subtypes make 
up the remaining 15% percent. These subtypes are primarily associated with the pre and post 
synaptic membranes. The delta subunit associating subtypes are only found peri and extra 
synaptically.  
GABAA receptors bind benzodiazepines barbiturates, anaesthetics, and neurosteroid. Identified 
in the 1980’s, drugs that stimulate the receptors enhance ethanol’s actions, whereas drugs that 
inhibit the receptors reduce ethanol’s affect, confirming ethanol’s action at the GABAA site. 
Overall ethanol works to activate GABAA receptors leading to a depression of action signal 
potential by hyperpolarisation. This is thought to contribute to the major depressive effects of 
ethanol on the CNS.  GABAA receptor subunit alpha has an identified binding site for ethanol. 
The site sits at A291 and has a pocket of water surrounding the amino acid. On ethanol binding 
the receptor conformation changes; opening the pore and allowing chloride entry.  
There have been many studies looking at the effects of ethanol on the subunit composition of 
the most predominant GABAA receptors; evidence suggests that ethanol may selectively 
increase activity for this receptor subtype although these studies have used high concentrations 
of ethanol. There is also a current search for binding sites that operate at low levels of ethanol 
exposure. There have been mixed reports for the activation of the extra-synaptic GABAA 
receptors with a subunit composition of 2ʱ42β2δ (Marutha Ravindran et al., 2007), but 
controversy remains over the concentrations of ethanol needed to activate the receptor (Lobo 
and Harris, 2008; Sundstrom-Poromaa et al., 2002). One of the main problems associated with 
subunit specific studies is the plasticity of the GABA receptor subunits when using knockout 8 
 
studies. Often there have been reports of subunit compensation in knockout models which may 
skew findings. The new focus is to analyse role of specific subunits with loss of function 
mutants. These may reflect a more distinct analysis of function. 
1.4.8  Glutamate 
Glutamate receptors exist in two forms, ionotropic non-selective cation channels and 
metabotropic GPCR. Glutamate is the main excitory neurotransmitter in the CNS. Glutamate 
receptors are found predominantly at the post-synaptic membrane. There are three subtypes of 
ionotropic receptor; NMDA, kainite and AMPA. These channels are permeable to cations and 
regulated by a number of ionic and peptide signalling pathways (Mattson, 2008). 
The NMDA receptor exists as a two subunit complex with a mandatory NR1 subunit and a NR2 
(A-D) subunit. The changes in subunit composition are temporally and spatially regulated. 
Further isoforms of the two subunit types exist due to differential splicing of transcripts. Both 
subunits have phosphorylation sites which enhance channel function. Phosphorylation by a 
number of different kinases has been linked to altered activity and trafficking of subunits. 
NMDA receptors require the cofactor glycine for its activation. In addition to these Mg
2+ is a 
blocker of NMDA receptor activity in a membrane voltage dependent manner (Kloda et al., 
2007).   
Ethanol inhibits the response of NMDA receptors in varying brain regions and is likely to be 
subunit dependent. Evidence suggests that there is a direct effect of ethanol on the NMDA 
receptor, either through a reduced potency of the agonist glycine or through subunit specific 
interactions (Nagy, 2008; Ridge et al., 2008). Post translational modification of NMDA 
receptors may also be affected by ethanol. Long term ethanol administration results in an 
upregulation of NMDA receptors to counter the depressive effects of ethanol (Nagy, 2008), 
although the precise temporal and subunit specificity of ethanol’s actions remain under debate. 
Ethanol withdrawal leads to hyperactivation of the NMDA receptors and is likely responsible 
for the convulsive and excitotoxic phenotypes in long term users. The result is that withdrawal 
from ethanol is potentially harmful and has to be treated with neuroinhibitory drugs such as the 
benzodiazepines.  
1.4.9  Endocannibinoids 
Endocannibinoids (EC) are believed to play a role in learning, memory, cognition, appetite and 
metabolic regulation. Cannibinoid receptors (CB) are found predominantly in the CNS and 
selective PNS target organs such as the kidneys, lungs, liver and immune system.  CB receptors 
are GPCR and exist as two receptor sub-types, CB1 and CB2. CB1 is mainly found in neural 
tissues whereas CB2 is mainly associated with the immune system. CB receptors are negatively 
coupled to the adenyl cyclase system and N and P/Q type calcium channels, whilst positively 
regulating A-type potassium channels and MAP kinases (Bisogno, 2008). 9 
 
Ethanol treatment either down regulates or desensitises CB receptors and thier G-protein 
mediated effect (Rubio et al., 2008). A mechanism of desensitisation is unclear, but the CB 
GPCR show desensitisation on dual ethanol treatment and agonist mediated constitutive 
activation, and it is plausible that ethanol may work in this manner. It has also been reported 
that G-protein levels and activity may be affected as a downstream or paralogous effect of 
ethanol’s actions on CB receptors. Tolerance is therefore linked to an upregulation of 
endocanniboids and their precursors. Much like with other neurotransmitter systems that are 
suppressed, withdrawal from ethanol results in a sensitisation of the CB system. 
It has been suggested that a lower function of CB receptors to ethanol may result in 
predisposition to alcohol preference (Vinod et al., 2008). Pre-treatment with SR141716A 
(Rimonabant), an inverse agonist of the CB1 receptor, has been found to decrease consumption 
and preference of ethanol (Dyr et al., 2008). Antagonism of CB1 reduces the motivation to drink 
ethanol and CB1 agonists facilitate ethanol consumption. CB1 deletion reduces preference to 
consume ethanol. It is likely then that CB receptors work to increase alcohol drinking and 
preference, and may play a role in the development to alcoholism (Malinen and Hyytia, 2008). 
1.4.10  Dopamine 
3, 4-dihydroxyphenylethylamine (dopamine) is a neurotransmitter and hormone, with 5 receptor 
subtypes each with their respective variations. Dopamine is synthesised in neurons where it is 
packed into vesicles for calcium mediated release into the synaptic cleft. D1 type receptors are 
D1 and D5, and activate adenyl cyclase through Gs G-protein. The D2 type receptors are D2, 
D3 & D4. The DAT is a dopamine transporter required for reuptake of dopamine into the pre 
synaptic node. It is what mediates signal strength and duration. DAT is unique to DA neurons 
and is found in the perisynaptic membrane rather than the cleft. Its action is sodium, potassium 
and temperature dependent, and is a target for a number of drugs, including cocaine (Foll et al., 
2009; Zhu and Reith, 2008). Dopamine is also a precursor to noradrenaline and adrenaline. 
Dopaminergic neurons are primarily present in the ventral tegmental area, the substantia nigra 
and arcuate nucleus of the hypothalamus. Dopamine primarily functions in reward, cognition, 
motivation and motor activity. It also has a role in pleasure, sexual interaction, salience, pain, 
sociability and psychosis. The most common attribute associated to dopamine function is in 
reward prediction error. Dopaminergic neurons are active at the receipt of a novel reward, and 
their activity dampened when no reward is produced. It is said that the affect mediates the 
feeling of wanting, and plays a major role in motivation. This is known as the mesolimbic 
reward pathway. 
Drug abuse stimulates release of dopamine from the nucleus accumbens and this is reduced on 
withdrawal; thus highlighting dopamine as one of the main pathways for reward and 
reinforcement of drug abuse (Foll et al., 2009). Changes in the dopamine system have been 10 
 
noted in animal and human studies; with reduced densities of dopamine transporters and D2 
receptors in alcoholics. Current work shows that the nucleus accumbens is a filter through 
which the effects of the dopamine system are mediated, controlling the link between desire and 
action. 
Ethanol has been shown to stimulate the release of dopamine from the nucleus accumbens in a 
dose dependent manner, by stimulating release rather than by inhibiting DAT. This is likely to 
be controlled by the ventral tegmental area (Wanat et al., 2009). It is also possible that ethanol’s 
action on other neurotransmitter systems leads to the increased release of dopamine. Withdrawal 
from ethanol promotes a reduction in dopamine release, and relief from withdrawal promotes 
dopamine release. The return of dopamine to basal levels after a continual exposure is in line 
with a tolerance affect. It has been suggested that the levels of basal dopamine and the release of 
dopamine on ethanol exposure are likely to mediate the differences in non-preferring vs. 
preferring rodent models. Alcohol preference in rats has been associated with lower Bmax of D2 
receptors, with unaltered binding preference in dopaminergic regions of the brain, whilst studies 
on D1 and D3 receptors remain inconclusive.  
1.4.11  Serotonin (5HT) 
5-hydroxytryptamine (serotonin) is a neurotransmitter involved in the modulation of anger, 
aggression,body temperature, mood, sleep, human sexuality and appetite. In addition to the 
CNS, serotonin is expressed in the gut, where it mediates cell to cell interactions. The main 
region of serotonergic neurons is in the brainstem’s raphe nuclei, with the axons projecting into 
the majority of brain areas. There are 7 serotonin receptors (1, 2, 3, 4, 5A, 6, 7) with receptors 
5HT1 and 5HT2 having 5 and 3 identified isoforms respectively. All of the receptors are 
metabotropic with the exception of 5HT3 which is ionotropic. 5HT receptors can modulate the 
effects of other neurotransmitter release such as glutamate. 
Serotonin is removed from the synaptic cleft by uptake through a monoamine transporter, either 
SERT or PMAT. It is these receptors that are implicated in the effects of cocaine. They are also 
targets for SSRIs (selective serotonin reuptake inhibitors) which are used to treat anxiety and 
mood related disorders. This is of interest because around 40% of alcoholics have anxiety 
related problems or have had prior history of anxiety related problems. It may indicate that 
levels of serotonin become altered over time in relation to alcohol abuse, or that genetic 
variation at the serotonin system level may be a risk factor for developing alcoholism (Caldwell 
and Miczek, 2008).  
Application of serotonin receptor antagonists reduce ethanol intake, whereas the application of 
exogenous serotonin increase the effects associated with ethanol. GPCR including 5HT 
receptors have their high affinity state inhibited by ethanol (Seeman and Kapur, 2003). Ethanol 
increases neuronal firing in the ventral tegmental area and decreases firing in Purkinje neurons 11 
 
with both these affects being enhanced by serotonin application. These affects are dependent on 
age, with aged rats not showing as significant affect (Jeng et al., 2000). The prevalence of 
alcohol use with age may have an effect on memory and learning; these may be mediated by 
serotonin. Oliveira-Silva et al. found that ethanol does not have any effect on age related 
memory and learning impairment and there is no change in 5HT levels related to age. This 
affect was independent of age extension via calorie restriction (Oliveira-Silva et al., 2007).  
Whilst it seems that the use of alcohol does not interact with the serotonin system in older 
models, the use of alcohol by pregnant women has been shown to have a significant affect. 
Ethanol exposure during pregnancy is associated with a variety of physical and neurological 
dysfunctions, giving rise to a spectrum disorder of foetal alcohol syndrome (FAS). Serotonin is 
vital for the development of the central nervous system and its altered role in development has 
been linked to ethanol consumption during pregnancy. The role of serotonin in development 
seems to be controlled through the 5HT1A receptor, which amongst other things causes the 
release of S-100β. S-100β is a growth factor with multiple outputs. Ethanol treatment increases 
serotonergic cells in the striatum and hippocampus in rat foetuses. There is also an increase in 
the area of GFAP staining, an astroglial cell marker, in the striatum and hippocampus, both 
areas affected in FAS. This links ethanol exposure to perturbed serotonin system which controls 
CNS development (Ramos et al., 2002).  
Serotonin is thought to be responsible for impulsivity and aggression. Alcohol also increases 
aggression in some individuals and is thought to be a major role in crime, with more than half of 
rapes, murders and related violence having the offender under the influence of alcohol (Krug et 
al., 2002). Projections in the prefrontal cortex are believed to regulate alcohol mediated 
aggression. The SSRI Citalopram has been shown to reduce anxiety and aggressive behaviours 
associated with ethanol. In mice Citalopram has no effect on alcohol mediated aggression in the 
first 2 weeks of administration, but after 17 days abolished alcohol mediated aggression whilst 
not affecting the baseline (Caldwell and Miczek, 2008). Chronic ethanol use is associated with 
long term changes including neuronal damage. Chronic ethanol consumption is correlated with 
neurodegeneration in the CA1 region of the hippocampus and reduced 5HTT staining, 
implicating the serotonin system (Tagliaferro et al., 2002). 
1.4.12   Opioid system 
The opioid system comprises of five main classes of endogenous opioid neurotransmitters; 
dynorphins, enkephalins, endorphins, endomorphins and nociceptin. There are three main 
classes of opioid receptor μ, δ, κ (MOR, DOR, and KOR), yet more remain but are under 
characterised ζ, ε (zeta, epsilon). In addition there is the ORL1 receptor for nociceptin. All the 
receptors are GPCR and are found primarily on GABAergic neurons. They are not limited to the 
CNS, they are also found around the digestive tract.   12 
 
The central amygdala is involved in mediating stress, fear and anxiety behaviours and is 
involved in the stress related behaviours of drinking, and possibly the reinforcing affects. MOR 
receptors and enkephalin are found in the GABAergic neurons of the central amygdala. The link 
between ethanol reinforcement and MOR is well established, although the mechanisms remain 
under debate (Kitanaka et al., 2008; Vukojevic et al., 2008), and knockout mice show reduced 
ethanol consumption and anxiety. MOR antagonists reduce ethanol consumption, and activation 
of DOR by agonists reduces ethanol consumption (Margolis et al., 2008; Nielsen et al., 2008). 
KO of the delta receptor show increased ethanol consumption. This highlights the role of MOR 
as a positively acting regulator of ethanol consumption and DOR as a negative regulator of 
ethanol consumption. 
Ethanol activates MOR in the central amygdala which decreases presynaptic transmission of 
glutamate and GABA. The decrease in GABAergic neurotransmission may also be dependent 
on corticotropin-releasing factor (CRF) (Kang-Park et al., 2009). The ventral tegmental area is a 
nucleus of dopaminergic neurons that is inhibited via GABAergic neurons. These GABA 
currents can be modulated by ethanol and MOR. Ethanol affects the presynaptic release of 
GABA and not the postsynaptic GABA receptors. DAMGO, a MOR agonist, and ethanol both 
inhibit GABAergic neurons. Both reduce GABA transmission and result in exciting 
dopaminergic neurons. MOR antagonists and competitive agonists reduce excitory effect on 
dopaminergic neurons (Xiao and Ye, 2008).  
Whilst the role of MOR and ethanol is to stimulate reward through activation of dopaminergic 
neurons, it appears that agonists of KOR inhibit the rewarding effects of ethanol. Both 
naltrexone and nalmefene, opioid receptor antagonists, reduce ethanol consumption in rats, with 
nalmefene decreasing the ethanol consumption in AP rats more than naltrexone. This is 
suggested to be because that nalmefene has a 2 fold higher binding affinity for KOR than 
naltrexone. Administration of nor-BNI, a KOR specific agonist, to dependent and non-
dependent rats reduced ethanol self-administration (Walker and Koob, 2008). This highlights 
the role of KOR in depression of alcohol consumption. 
1.4.13  mAChRs 
Muscarinic acetyl choline receptors have 5 receptor subtypes (m1-m5) all of which are G-
protein coupled receptors. M1, M3 and M5 receptors are positively coupled to PLC by Gq 
protein, whilst M2 and M4 receptors are coupled negatively to adenyl cyclase by Gi protein. M1 
receptors are expressed in all major brain areas while M2 are limited to the forebrain as a 
presynaptic auto-receptor that works to inhibit neurotransmitter release. M3 receptors are 
expressed mainly in the smooth muscle. The M4 receptor is mainly expressed in the striatum 
and colocalised with dopamine D1 receptors, but is not limited to this area. The M5 receptors 
are expressed in the substantia nigra and ventral tegmental area. The expression pattern of M4 13 
 
and M5 receptors suggests a role in drug reinforcement, although there is little evidence for a 
role in these behaviours. 
mAChR antagonists increase locomotory activity on ethanol treatment and this affect is 
independent from dopamine. Treatment with scopolamine, a non-specific receptor mAChR 
antagonist, produced locomotory activity increases in ethanol treated FAST and DBA/2J mice 
greater than either drug alone. Treatment with D2 and D1 receptor antagonists was unable to 
stop this affect (Scibelli and Phillips, 2009). Ethanol has also been found to be a potent inhibitor 
of muscarinic receptor-stimulated proliferation of astroglial cells, with an IC50 of 10–25 mM. 
Activation of M3 receptors by carbachol causes this proliferation by downstream activation of 
DNA synthesis, and this affect is inhibited by ethanol possibly by interfering with activation of 
the downstream targets PKCζ and p70S6K (Guizzetti and Costa, 2002). Acetylcholine is 
associated with learning and memory consolidation, and changes in mAChRs seem to correlate 
well with ethanol induced deficits in memory and learning. Previous studies point to an increase 
of mAChRs on the cell surface in SH-SY5Y cells treated chronically with ethanol (Caron and 
Alling, 2001). This upregulation of mAChRs seems to be a functional response to ethanol 
treatment inhibiting mAChRs. We also note that ethanol causes an upregulation in M4 mRNA, 
but not M1 in NG108-15 and NCB-20 cells (Fukamauchi et al., 1998). It is unclear as of yet 
what these functional changes in mAChR regulation are responsible for in ethanol related 
behaviour, but it may play a role in acute ethanol stimulation on locomotory activity. 
1.5  Behavioural effects of ethanol in C. elegans 
Whilst several molecular targets for ethanol have been identified above they only offer a brief 
glimpse into the behaviour of C. elegans on ethanol treatment. As the response to ethanol is 
context and dose dependent it is important to distinctly identify the behaviours associated with 
each state, from acute treatment through to chronic treatment and the plastic changes that 
underlie further behavioural changes. It is by classifying these behavioural states as distinct and 
paradigm-dependent that we are able to build a platform from which to investigate the 
molecular basis of ethanol activity. Difficulty has always arisen in trying to classify a spectrum 
of behavioural changes into distinct states, but it is essential for clarification in experimentation 
and understanding. Here we aimed to identify behavioural states associated with acute 
intoxication, treatment withdrawal, withdrawal relief and chronic tolerance. Vital to 
understanding how alcohol works at a molecular level is a need to control the dose of ethanol 
looked at; further investigation into lower sub-intoxication doses and behaviour are also 
investigated.  
Primarily focus turns to previously developed assays for measuring the dose dependent effect of 
ethanol with the study of worm locomotion and chemotaxis. Locomotion is defined by a stretch 
sensitive control of sinusoidal body movement over a substrate, starting with a directed head 14 
 
movement. It works to propel the worm over an environment. It is also regulated by several 
over-riding behaviours which work to control direction and speed, such as escape from a 
nocioceptive response or towards a chemo-attractant. Chemotaxis; the movement of the worm 
towards a chemical stimuli can also be used as a measure of behaviour. Ethanol as a depressant 
works to inhibit locomotion and therefore inhibits chemotaxis. This can be used to assess the 
behaviour of worms on varying ethanol treatment paradigms. 
Pharyngeal pumping is vital to worm function; it regulates the passing of bacterial foodstuffs 
into the gut passage. It can also be used as a behavioural measure of ethanol intoxication. The 
pharynx is a somewhat distinct microcircuit of neurons regulated by sensory inputs of food 
availability. Food activates pharyngeal pumping and withdrawal from food suppresses pumping. 
The pharynx can be used as an estimate of how pharmacological agents such as ethanol can 
regulate a semi isolated neuronal system and a simple behavioural output. 
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2  Ethanol Mediated Behaviour 
2.1  Introduction 
Ethanol is a major source of morbidity and mortality, responsible for 2.5 million deaths annually 
worldwide. Understanding the mechanism of alcohol intoxication and addiction is of major 
medical value. To study ethanol in a behavioural and physiological context we can utilise the 
nematode worm Caenorhabditis elegans as an experimental system (See 1.4 and 1.5). C. 
elegans, much like other organisms, has distinct behavioural phenotypes dependent on the 
concentration of ethanol and treatment paradigm. Acute and chronic intoxication, withdrawal, 
relief from withdrawal and tolerance are all shown as separate behavioural phenotypes. These 
behaviours are underpinned by distinct molecular effectors that act in concert to regulate the 
overall physiological response. By identifying the components it should help to understand the 
possible mechanisms of ethanol response in higher organisms and how behaviour is controlled 
at a molecular level. 
2.1.1  Ethanol toxicity and response in C. elegans 
C. elegans is under-utilised for dissecting the pharmacological action of ethanol compared to 
other experimental models. Nevertheless, C. elegans represents a useful model for ethanol 
experimentation and has contributed to understanding the molecular basis of ethanol response. 
Using C. elegans to model different behavioural states allows the investigation of the underlying 
regulation. This requires C. elegans to show acute responses to ethanol and behavioural 
plasticity to chronic treatment. This is explored further below. 
2.1.2  Locomotion in C. elegans 
Locomotion is defined as the power or ability to move. In C. elegans it is characterised by an 
undulatory wave that acts to propel the organism forward. Locomotion begins with a controlled 
directional movement of the worms head; this in turn causes stretch receptors directly posterior 
of the head to detect a change in tension in the cuticle/surface of the worm. The components that 
make up the nervous system and muscular controls utilised in worm locomotion are often 
homologous to components in the mammalian and human nervous system, although not always 
in directly analogous roles. It is these networks and molecular machinery which are affected by 
ethanol intoxication, thus by studying locomotion in C. elegans we can gain an insight into the 
possible mechanisms that control human behaviour. 
2.1.2.1  Chemotaxis assays and quantitative measure of ethanol effects 
Locomotion towards a cue as a result of directed behaviour is called chemotaxis. In C. elegans 
the cue is often a chemical substance associated with the presence of bacterial food. Worms will 16 
 
chemotax towards gradients of ions, cyclic nucleotides, organic molecules and bacterial species. 
Movement towards a cue is controlled in a similar way to the random tumble movement 
exhibited by bacteria. Worms will move up a gradient of an attractant, comparing temporal 
changes in gradient concentration and deceasing turn frequency on movement towards source, 
whilst increasing turn frequency on movement away from a food source. This behaviour results 
in a biased random ‘walk’ towards a cue. 
The presence of food in C. elegans suppresses turning behaviour and slows locomotion; 
maximising time spent in the presence of a food source (Maricq et al., 1995). This behaviour is 
switched off in when the worm is no longer in a food rich environment. Behaviour changes to a 
temporally controlled search mode. The initial response, from 0 to 15 min, is to switch to local 
area search. Turn frequency is increased as is the omega turn count. Speed increases from 
feeding levels and the angle of each turn increases. The result is a restricted search pattern to the 
immediate area around the worms starting position. This reduces chance of missing food 
sources that lie in the immediate vicinity. If food is not found after 15-20 min the worms then 
switch to long distance search behaviour. Turn frequency, angle and omega turn frequency are 
decreased whilst speed increases slightly. This has the effect of a more long distance movement 
away from the starting position to ever distant food sources. This behaviour switch is made after 
a local search for foods sources. 
2.1.3  Pumping behaviour in C. elegans 
C. elegans will often chemotax towards cues indicative of a food source. Feeding in C. elegans 
is regulated by pharyngeal pumping. The pharynx is the lumen, musculature and neuronal 
network that sits in the head of the worm at the entry to the gut cavity. The pharynx acts as a 
pump that draws in bacterial food during feeding. It is regulated by a small number of neurons 
(twenty) that are connected to the rest of the central nervous system by a single direct neuronal 
connection mediated by RIP. Thus the microcircuit that regulates pumping is unique in that it is 
almost completely isolated from other inputs. In addition the pharynx and its distinct 
microcircuit can be dissected from the worm and studied without the worm body. Again the 
circuit provides a useful tool in which to study the regulation of an almost isolated system of a 
small number of neurons which uses the same components as a more complex system in higher 
organisms.  
2.1.4  Ethanol concentrations in C. elegans & Humans 
Alcohol levels between humans and C. elegans are not directly comparable. Levels able to 
cause acute and chronic intoxication in C. elegans, are fatally toxic to humans by many 
magnitudes. Human blood alcohol content (BAC) of 0.10% by volume, (22mM) just over the 
drink drive limit in the UK, and enough to cause impairment of motor function and changes to 
behaviour. C. elegans however does not show any impairment of motor function until around 17 
 
150mM, and severe impairment at 300mM after prolonged exposure. It is unknown why these 
differences in exposure concentrations are so great. It can be speculated that C. elegans has 
adapted to an environment rich in alcohol, such as rotting fruit, and evolved some resilience to 
exposure. Others have suggested that the cuticle may provide an entry barrier to ethanol 
diffusion, and that levels measured suggest a lower more analogous concentration exists 
internally in the worm (Davies and McIntire, 2004). Experimentation has shown that the lipid 
cuticle provides little barrier to ethanol and that behaviours present on ethanol exposure are not 
dependent on a cuticle, such as pharyngeal pumping (Mitchell et al., 2007).  
The concentration of ethanol used to test C. elegans is one to illicit behaviours that are partially 
analogous to the behaviours seen in other organisms such as humans and mice, and not directly 
linked with BAC or exposure concentrations. Whilst slightly limiting, C. elegans still provides a 
strong platform for an ethanol led investigation into the molecular basis of behaviour. 
2.2  Methods 
2.2.1  Media  
2.2.1.1  NGM 
Nematode growth media; used as a substrate for worm culture and experimentation. For 5 litres: 
NaCl  12g 
Peptone  10g 
Agar  80g 
H2O  3888ml 
 
Put a large magnetic stirrer bar in a 5l bottle, autoclave, cool to hand hot (~55° C) stirring 
continuously for about 1 to 1.5hrs and then add: 
CaCl2   (1M)  4ml  (autoclaved) 
MgSO4  (1M)   4ml  (autoclaved) 
K
+ Phosphate buffer  (pH6)  100ml  (autoclaved) 
Cholesterol  (5mg/ml)         4ml  (stored at -20˚C) 
 
A Peristaltic pump is used to aliquot 10ml NGM into 55mm Petri dishes.  Tubing for the pump 
wrapped in aluminium foil must also be autoclaved. 
To reduce contamination, the area of bench used for plate pouring is swabbed down with 70% 
ethanol, and gloves are used for the entire procedure. 18 
 
NGM plates are left to ‘dry’ (with the lids on) at 20°C for 24 - 48hours before seeding with 
OP50. 
Plates destined for use in ethanol experimentation are devoid of cholesterol, to eliminate any 
residual effects from the ethanol used to store the cholesterol remaining in the media. 
2.2.1.2  Potassium Phosphate Solution 
Potassium Phosphate; used as a pH buffer in nematode growth media. For 1 litre: 
K2HPO4  23g  (0.132M) 
KH2PO4  118.12g (0.868M) 
H2O  to 1L 
Autoclaved 
2.2.1.3  E. coli OP50 cultures 
LB agar plates streaked with OP50 are incubated at 37° C overnight, then sealed with parafilm 
and stored at 4° C. 
A fresh plate is streaked with OP50 every month. 
Individual colonies of OP50 are grown overnight in 10ml of LB broth in sterile universal 
bottles, on a shaker at 37°C.  50μl of this bacterial suspension is pipetted at the centre of each 
NGM plate (without spreading). Seeded plates can be stored at room temperature (20°C) for up 
to 2 weeks. 
2.2.1.4  LB Broth 
LB Broth is used as a nutrient source for liquid cultures of E. coli OP50. For 1 litre: 
Bacto-tryptone  10g 
Yeast extract  5g 
NaCl  10g 
Added the to 800ml H2O  
Adjust pH to 7.5 with NaOH.  
Adjust volume to 1L with dH2O 
2.2.1.5  M9 Buffer 
M9 buffer is used to wash worms in preparation for experimentation. For 1 litre of M9 Buffer: 
KH2PO4  3g 
Na2HPO4  6g 19 
 
NaCl  5g 
MgSO4 (1M)  1ml 
H2O  to 1L 
Autoclaved 
2.2.2  Nematode culture  
2.2.2.1  Escherichia coli OP50 culture.  
E. coli OP50 strain was cultured in LB Broth at 38°C. Cultures were grown in liquid media at a 
culture density of 0.8 absorbance at optical density 600 [OD600], exponential growth phase, 
before transferring to nematode growth media for C. elegans assays. Heat killed OP50 was 
heated in a water bath at 70°C for 30 min before being transferred to nematode growth media. 
2.2.2.2  Nematode strains.  
C. elegans strains were maintained with standard nematode culture techniques (Brenner, 1974) 
at 20°C unless otherwise stated. The wild type reference strain was (Bristol) N2. The zdIs4 
strain was from the C. elegans Genetics Centre (CGC) and contained an integrated plasmid 
containing an 1.1kb genomic fragment of the upstream promoter region of hsp-4 fused to GFP 
(hsp-4::GFP). zdIs4 was expressed GFP at low levels across the worm; predominantly in cells 
adjacent to the gut. Upon increase in unfolded protein stress the cells increased GFP expression.  
The zdIs4 strain was out crossed five times. The gk514 strain from the CGC and contains a 
mutation in the hsp-4 gene on chromosome II. The gk514 strain was out crossed once. The 
pmyo2::GFP  strain  expresses  GFP  in  the  pharynx  and  contains  a  neuronal  specific,  partial 
rescue of slo-1. 
2.2.2.3  Worm preparation.   
All worms were transferred to separate culture plates 24 hours prior to experiments. Transferred 
worms were selected at larval stage 4 (L4) and allowed to mature into adult worms overnight. 
These adult worms were then used for the worm race, pumping and dispersal assays. 
2.2.2.4  Ethanol concentrations in plates.  
Samples of agar, 1cm x 1cm cubes, were collected from ethanol treated and untreated (control) 
test plates. Agar samples weights were recorded. Samples were sonicated for 1 h in 1 ml of 
ddH2O. Sigma NAD-ADH test vials were made up to 16 ml with ethanol test buffer solution 
(100ml of 3.75g of glycine, 5.84g of NaCL in ddH2O, made to pH 9 with NaOH). 20 μl of post-
sonication sample solutions were added to 600 μl of NAD-ADH test solution. Samples of 
ethanol solution at concentration 0, 10, 20, 40, 100, 200 mM were used for calibration. 20 μl of 
the calibration samples were added to 600 μl of NAD-ADH test solution. All samples were 
replicated 3 times. All samples were then incubated at 37°C for 10 min before recording the 20 
 
absorbance of each sample at 340 nm. Sonication of the agar samples removes the alcohol from 
the agar to the ddH2O. The alcohol can then be treated with alcohol dehydrogenase (NAD-ADH 
test solution) for a set time and the absorption spectra of the reaction product measured. The 
absorbance gives an indirect measure of the alcohol present in the solution and therefore in the 
mass of the agar sample. Comparison against a concentration curve of known samples gives an 
indication of the concentration in the test plates. 
2.2.3  Worm race assay 
2.2.3.1  Worm race assay.  
9cm culture plates were hand poured with 25 ml of NGM agar and left  to set for 24h. 9cm 
plates were marked at two points at a distance of 5cm apart. The two points marked the E.coli 
food spot and the worm starting position. One point was seeded with 50 μl of E. coli OP50 at 
0.8A [OD600], ensuring that the E. coli was limited to a single culture spot. 6cm machine poured 
stock plates were seeded with a centrally placed spot of 50 μl of E. coli OP50 at 0.8A [OD600] 
and incubated for 24 hrs.  
Seeded plates were treated with ethanol to give a final concentration of either ~50 mM or 300 
mM. Ethanol was pipetted directly onto the agar surface; volumes of ethanol were often such 
that the ethanol would cover the entire plate surface. Plates were incubated 24h for ethanol to 
equilibrate across agar, with plate lid covers sealed up until experimentation to avoid 
evaporation.  
50L4 + 1 day worms were transferred to conditioning plates for 6 hours. Worms were rinsed off 
6cm plates with 1ml of M9 and transferred into an Eppendorf tube. Worms were allowed to 
settle for 5 min and form a loose pellet before removal of the supernatant. A further 1ml of M9 
buffer was added and left for 5 min. Supernatant was removed leaving a loose pellet of worms 
in approximately 30 μl of solution.  
Worms were transferred to 9cm plates on the marked point 5cm opposite the food and the 
transfer spot allowed to dry. When no liquid remained timing for that food race began. The 
mean transfer rate for worms, incorporating losses from washing and transfer, was 60% (i.e. 
60/100 worms). E. coli food spot was checked every 10 min for 2 hours and the number of 
worms recorded. The worms on the food were removed after counting at 10 min intervals. The 
number of worms left on the plate after 2 hours that have not reached the food spot was also 
recorded. A representative plate from the 6cm conditioning plates and 9cm race plates were kept 
after the assay to measure ethanol concentration.  21 
 
2.2.4  Pumping assay 
2.2.4.1  Pumping assay preparation.  
Growth media used in all assays contained 0.8A [OD600] OP50 grown for 2 days. All assays 
except food lawn assays used a 50 μl spot of OP50. Food lawn assays used a 100 μl OP50 spot 
spread over the entire culture plate with a glass plate spreader before 2 days growth. Ethanol 
was added 1 day before starting all assays. All assays were done under a temperature controlled 
environment at 21°C. Treatment types were blinded unless noted. 
2.2.4.2  Pumping experiment.  
Single adult worms were transferred to OP50 seeded plates for 5 min before recording 
pharyngeal pumping rate. Worms were transferred to an unseeded plate and allow to crawl free 
of bacteria for a further 5 min. Worms were then transferred to the unseeded test plates and 
pumping was recorded at 5, 20, 40 and 60 min time intervals. Worms were then transferred back 
to an OP50 seeded culture plate for a final 5 min before again recording pumping rate. Pumping 
rate was recorded for 1 min using a hand counter. Worm presence or absence from OP50 food 
spots at both beginning and end transfers was recorded where noted. 
2.2.4.3  Pumping on food assay.  
Single adult worms were transferred to a culture plate containing a lawn of OP50 bacterial food. 
After 5 min pumping rate was recorded using a hand counter for 1 min. 
2.2.4.4  Pumping off food assay.  
Single adult worms were transferred to an unseeded cleaning plate for 5 min to crawl free from 
bacterial food. Worms were then transferred to an unseeded culture plate for 60 min. Pumping 
rate was recorded at the 5, 20, 40 and 60 min intervals using a hand counter for 1 min. 
2.2.5  Dispersal assay 
2.2.5.1  Dispersal assay.  
15 adult worms were transferred directly on the OP50 of a centrally seeded culture plate and the 
number of worms remaining on the food at 1 min or 5 min intervals, for the 10 min and 60 min 
durations respectively, was recorded.  
2.2.5.2  Dispersal on heat killed OP50 food.  
Worms were transferred to plates as in the dispersal assay but using heat killed OP50 and 
compared to experiments using live OP50.   
2.2.5.3  Transferred food dispersal assay.  
OP50 food was grown on separate culture plates, either pre-treated with ethanol or non-treated. 
Prior to running the dispersal assay the OP50 food spots were excised from the pre/non-treated 
plates and placed onto unseeded pre/non-treated destination plates. The OP50 was placed such 22 
 
that the bacterial spots were pressed against the destination plate. Pressure was applied and 
given 1 min to settle before the OP50 was removed, leaving a transferred spot of OP50 on the 
destination plate. The dispersal assay was then run using the destination culture plates.  
2.3  Results 
2.3.1  Food race assays 
C. elegans N2 strain were treated with varying concentrations of ethanol either during 
(intoxication), or for 6 hours prior (withdrawal) to, a food race assay. The food race assay 
quantifies the chemotaxic of the worm can be used in combination with ethanol to define 
distinct ethanol states. Untreated Worms had a mean 75% of the population reach the food after 
a period of 2 hours, N=16 (Figure 2.1A).   
Worms treated with 50 mM ethanol during a food race after 6 hours conditioning with no 
treatment, an acute low dose of ethanol, were not significantly different from control worms 
receiving no treatment at 2 hours, [Unpaired t-test, P>0.05] (Figure 2.1B). After 2 hours a mean 
72% of untreated, control worms made the food reward. Similarly after 2 hours a mean 72% of 
50 mM ethanol treated worms made the food reward in the control paired race assays, N= 7. 
Worms treated with 300 mM ethanol during a food race after 6 hours conditioning with no 
treatment, an acute high dose of ethanol, were significantly different from control worms 
receiving no treatment at 2 hours, [Unpaired t-test, P<0.001] (Figure 2.1C). After 2 hours a 
mean 68% of untreated, control worms made the food reward. In comparison after 2 hours a 
mean 3% of 300 mM ethanol treated worms made the food reward in the control paired race 
assays, N=6.  
Worms treated with no ethanol during a food race after 6 hours conditioning with 300 mM 
ethanol, withdrawal from ethanol, were significantly different from control worms receiving no 
treatment at 2 hours, [Unpaired t-test, P<0.05] (Figure 2.2A). After 2 hours a mean 74% of 
untreated, control worms made the food reward. In comparison after 2 hours a mean 52% of 300 
mM ethanol withdrawn worms made the food reward in the control paired race assays, N=10. 
Worms treated with 50 mM ethanol during a food race after 6 hours conditioning with 300 mM 
ethanol, relief from withdrawal, were not significantly different from worms treated with no 
ethanol during a food race after 6 hours conditioning with 300mM ethanol, withdrawn, at 2 
hours [1 way ANOVA with Bonferroni correction, P>0.05] (Figure 2.2B). Both relieved and 
withdrawn worms were significantly different from untreated, control worms at 2 hours [1 way 
ANOVA with Bonferroni correction, P<0.05]. After 2 hours a mean 77% of untreated, control 
worms made the food reward. In comparison after 2 hours a mean 56% of 300 mM ethanol 
withdrawn worms and a mean 60% of 50 mM ethanol relieved worms made the food reward in 
the control paired race assays, N=10. 23 
 
Worms treated with 300 mM ethanol during a food race after 6 hours conditioning with 300 mM 
ethanol (“ethanol tolerant”) were not significantly different from worms treated with 300 mM 
ethanol during a food race after 6 hours conditioning with no ethanol, an acute high dose of 
ethanol, at 2 hours [1 way ANOVA with Bonferroni correction, P>0.05] (Figure 2.3). Both 
tolerant and acutely intoxicated worms were significantly different from untreated, control 
worms at 2 hours [1 way ANOVA with Bonferroni correction, P<0.001]. After 2 hours a mean 
79% of untreated, control worms made the food reward. In comparison after 2 hours a mean 5% 
of 300 mM ethanol tolerant worms and a mean 7% of 300 mM ethanol intoxicated worms made 









Figure 2.1. Food race of N2 worms on increasing ethanol concentrations.  
N2 worms untreated were raced over a distance of 5cm towards a food reward. The population of 
worms reaching the food was recorded every 10 min for 2 hours, with the number of worms left after 
2 hours also recorded. (A) No ethanol. 75% ± 2.2 SE of the population reached the food after 2 hours, 
N= 16; (B) N2 worms treated with 50 mM ethanol (Low ethanol) and no ethanol (Control). 72% ± 1.2 
SE of 50 mM ethanol treated worms reached the food after 2 hours, whilst 72% ± 2.9 SE of untreated, 
control worms reached the food race after 2 hours, N=7. There is no significant difference between 
treatments; (C) N2 worms treated with 300 mM ethanol (High ethanol) and no ethanol (Control). 3% ± 
0.9 SE of 300 mM ethanol treated worms reached the food after 2 hours, whilst 68% ± 1.7 SE of 
untreated, control worms reached the food race after 2 hours, N=6. Results are significantly different 







Figure 2.2. Effect of withdrawal from ethanol on food race assay. 
N2 worms were raced over a distance of 5cm towards a food reward. The population of worms 
reaching the food was recorded every 10 min for 2 hours, with the number of worms left after 2 hours 
also recorded. (A) worms conditioned with 300 mM ethanol and then raced on no ethanol 
(Withdrawn),  and untreated worms (Control). 52% ± 4.0 SE of 300 mM ethanol conditioned worms 
reached the food after 2 hours, whilst 74% ± 4.0 SE of untreated, control worms reached the food race 
after 2 hours, N=10. Results are significantly different between treatments (Unpaired t-test, P<0.05). 
(B) As in A, plus worms conditioned with 300 mM ethanol and then raced on 50 mM ethanol (Relief). 
56% ± 3.6SE of 300 mM ethanol conditioned worms reached the food after 2 hours, whilst 60% ± 6.3 
SE of 50 mM ethanol relieved worms reached the food. 77% ± 3.5 SE of untreated, control worms 
reached the food race after 2 hours, N=10. Results are not significantly different between ethanol 
treatments, but are significantly different from control worms (ANOVA, P<0.05). 26 
 
 
Figure 2.3. Effect of pre-conditioning with 300mM ethanol on food race assay. 
N2 worms treated with 300 mM ethanol (Intoxicated), conditioned with 300 mM ethanol and then 
raced on 300 mM ethanol (Tolerant) and untreated worms (Control) were raced over a distance of 
5cm towards a food reward. The population of worms reaching the food was reordered every 10 min 
for 2 hours, with the number of worms left after 2 hours also recorded. 5% ± 1.473 SE of 300 mM 
ethanol tolerant worms reached the food after 2 hours, whilst 7% ± 2.385 SE of 300 mM ethanol 
intoxicated worms reached the food. 79%± 2.983 SE of untreated, control worms reached the food 
race after 2 hours, N=10. Results are not significantly different between ethanol treatments, but are 
significantly different from control worms. 
 
2.3.2  Investigating the use of pumping assays to define dose-dependent effects of 
ethanol 
The initial experiments focused on the pumping rate of individual worms with and without food. 
Unpublished observations suggested that low dose effects <50 mM) could be resolved when 
using electrophysiological recording of pharyngeal pumping (James Dillon, pers. comm.). We 
tried to verify this using an assay featuring intact animals. Worms were placed on food for a 5 
min period either side of a 1 hour period off food. The rate of pumping on and off food was 
observed over this period. Treatments included 50mM ethanol (Figure 2.4) and a higher 300mM 
dose (Figure 2.5).  
There was an initial response to ethanol on food. Pumping rate is lower in 50mM ethanol treated 
worms (Figure 2.4) at the first time point. This response was lost at the later time point of 70 
min when the worms are returned to food. Unrecorded observations during the non-blinded, trial 
phase (Figure 2.4A) showed that worms often moved from the food spot on which they were 
placed. It was hypothesized that the worms were showing a lower pumping rate because worms 
were slowing pumping in response to a non-food environment, not because the low 
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Figure 2.4. Pumping assay on and off food in the presence of 50mM ethanol. 
A. Adult worms were treated with 50mM ethanol (Ethanol) or left untreated (Control). Pumping rate 
was measured on food after 5 min (-10 min), off food (5, 20, 40 & 60 min) and then back on food (70 
min). Points represent mean pumping rate. Control N = 38, Ethanol N = 38. Error bars represent ± 
S.E.M. B. Repeat analysis, blinded to treatment type; return to food measurement taken at 65 min. 
2.3.2.1  High dose effects 
Treatment with high 300mM ethanol caused an inhibition of pumping both on, off and when 
returned to food (Figure 2.5). This is consistent with the previously reported dose-dependent 
inhibition of locomotion in food race assays (data not shown).  28 
 
During the observations required to make pumping measurements on food, I noted that the 
worms dispersed from the food. The dispersal rates of the ethanol treated worms show a higher 
rate of dispersal than their control counterparts (Table 2.1). This confounds pumping 
measurements, as food is a major trigger for pumping. 
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Figure 2.5. Pumping assay on and off food in the presence of 300mM ethanol. 
Adult worms were treated with 300mM ethanol (EtOH) or left untreated (Control). Pumping rate was 
measured on food after 5 min (-10 min), off food (5, 20, 40 & 60 min) and then back on food (65 min). 
Points represent mean pumping rate. Control N = 38, Ethanol N = 38. Error bars represent ± S.E.M. 
 
Table 2.1. Pumping assay dispersal from food, blinded. 
Adult worms were treated with 300mM ethanol (EtOH) or left untreated (Control). Values represent 
dispersal over all repeats. Control N = 38, Ethanol N = 38.  
Treatment  Worms off food (%) 
-10 min  +65 min 
Ethanol  78  56 
Control  14  11 
 
2.3.2.2  Pharyngeal pumping on bacterial lawns 
To avoid problems with dispersal from food, pharyngeal pumping was also assayed on food 
plates seeded with a bacterial lawn. Worms cannot therefore ‘escape’ the food signal. Pumping 
was assayed at four ethanol treatment concentrations: 25mM, 50mM, 150mM and 300mM. 
Treatment groups were blinded. Of the 4 treatment groups none showed any significant 
difference from control treatments, apart from the 300mM ethanol treatment, which reduced 29 
 
pharyngeal pumping (Figure 2.6). Median pumping in groups Control and 25mM ethanol were 
209.5 and 202.5 pumps per minute; the distributions in the two groups did not differ 
significantly (Mann–Whitney U = 1898, n1 = n2 = 60, P > 0.05 two-tailed, P = 0.6101). Median 
pumping in groups Control and 50mM ethanol were 214 and 219 pumps per minute; the 
distributions in the two groups did not differ significantly (Mann–Whitney U = 1982.5, n1 = 50, 
n2 = 68, P > 0.05 two-tailed, P = 0.1236). Median pumping in groups Control and 150mM 
ethanol were 220 and 208 pumps per minute; the distributions in the two groups did not differ 
significantly (Mann–Whitney U = 125, n1 = n2 = 16, P > 0.05 two-tailed, P = 0.4641). Median 
pumping in groups Control and 300mM ethanol were 220 and 44.5 pumps per minute; the 
distributions in the two groups differed significantly (Mann–Whitney U = 31.5, n1 = n2 = 16, 
P < 0.05 two-tailed, P = 0.0003). 
These results are in contrast to the previous experiments where worm dispersal behaviour led to 
a decreased pumping rate on food. 
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Figure 2.6. Effect of increasing ethanol concentrations on pumping rate on a bacterial lawn. 
Pumping assay on food, blinded. Adult worms were treated with 25mM (A), 50mM (B), 150mM (C) or 
300mM (D) ethanol (Ethanol) or left untreated (Control). Pumping rate was measured on food after 5 
min. Bars represent mean pumping rate. Control N = 60, Ethanol N = 60 (A), Control N = 60, Ethanol N 
= 68 (B), Control N = 16, Ethanol N = 16 (C) and Control N = 16, Ethanol N = 16 (D). Error bars represent 
± S.E.M.  
2.3.2.3  Pharyngeal pumping off food 
Pumping off food at 150mM shows a slight increased pumping rate over control worms initially 
but soon decreases (Figure 2.7B). This may be a stimulatory effect of ethanol at a short time 
point before a more chronic inhibition of pumping later on. Adapted graphs from Figure 2.4 and 
Figure 2.5 are shown for comparison (Figure 2.7A & Figure 2.7C). It is worth noting that these 
graphs may not show any early time point stimulation of pumping rate due to an additional 
treatment in ethanol for 10 min prior, the food phase. The variability in the 150mM ethanol 
treatment is likely due to the lower N numbers. 31 
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Legend on next page. 32 
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Figure 2.7. Pharyngeal pumping assay off food, blinded. 
Pumping assay off food, blinded. Adult worms were treated with 50mM (A), 150mM (B) & 300mM (C) 
ethanol (EtOH) or left untreated (Control). 50mM (A) and 300mM (C) graphs adapted from Figure 2.4B 
and Figure 2.5 respectively. Pumping rate was measured off food at 5, 20, 40 & 60 min. Points 
represent mean pumping rate. Control N = 18, Ethanol N = 18 (B), Control N = 38, Ethanol N = 38 (A & 
C). Error bars represent ± S.E.M. 
2.3.3  Worm dispersal: a novel assay for alcohol effects 
In addition to informing the design of the pumping assays the dispersal offered a novel ethanol 
assay. We thus sought to define basis of the response. 15 worms were placed on a food spot, as 
in the pumping assay, and the number of worms that stayed on the food over time was counted. 
Worm dispersal was observed over a 10 min period on 50mM ethanol, and at a longer 60 min 
period (Figure 2.8). In addition the dispersal assay was extended to include a range of ethanol 
concentrations (0-300mM) over 10 min (Figure 2.9). Treatment type was blinded in all 
experiments. 
Treatment with 50mM ethanol causes worms to move away from the OP50 food spot after just 1 
minute. Approximately 50% of the population move away after this time and remain off for the 
duration of 10 min. Untreated worms have approximately 90% of the population stay on the 
food, with little variation over time. Extending the treatment duration from 10 to 60 min results 
in a slight increase in the worms that stay on the food, with around 75% of the ethanol 
population on returning to food after 60 min. Although individual worms were not recorded this 





















































































Figure 2.8. Dispersal from food assay for short and long time periods.  
15 adult worms were treated with 50mM ethanol (Ethanol) or left untreated (Control) for 10 min (A) 
or 60 min (B). Dispersal rate from food was measured at 1 min (A) or 5 min (B) intervals. Points 
represent mean dispersal rate. Control N = 10, Ethanol N = 10. Error bars represent ± S.E.M. 
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Figure 2.9. Dispersal from food assay for increasing ethanol concentrations. 
15 adult worms were treated with 25mM (A), 50mM (B), 150mM (C) or 300mM (D) ethanol (Ethanol) 
or left untreated (Control) for 10 min. Dispersal rate from food was measured at 1 min intervals. 
Points represent mean dispersal rate. Control N = 10, Ethanol N = 10. Error bars represent ± S.E.M. 
50mM graph (B) as Figure 2.8; repeated for comparison. 
 
Increasing ethanol treatment causes C. elegans to disperse away from the food with a maximal 
dispersion at 150mM (Figure 2.9C). At 150mM approximately 35% of the worms are away 
from the OP50 food at 10 min. At the higher 300mM concentration the worms show a reduced 
propensity to disperse from the OP50 food, with perhaps ethanol inhibiting locomotion such as 
to hinder dispersal. The lowest ethanol concentration 25mM shows worms initially dispersing, 
but then recovering to baseline levels seen in control, untreated worms over time. This is likely 
the threshold for a dispersal phenotype. 
There are 2 distinct possibilities which can explain the results above. Either the worm’s 
behaviour is directly modified by ethanol interacting with the worm, or the presence of ethanol 
is changing the bacterial environment and indirectly modifying behaviour. To address this issue, 
an experiment was designed to investigate whether ethanol treatment had an effect on the OP50 
bacterial food itself.  35 
 
2.3.3.1  Worm dispersal on heat-killed bacteria 
Worms were treated with either 50mM ethanol or no treatment in the presence of alive or heat 
killed bacterial food. If the bacteria were acting as a cue, rather than ethanol acting directly on 
the worms, then using heat killed bacteria, which cannot metabolise ethanol, would remove the 
dispersal phenotype. Likewise, if the worms were being affected by ethanol then heat-killed 
OP50 would not affect dispersal behaviour. 
There is no observable difference between those on 50mM ethanol and dead OP50 versus dead 
OP50 without ethanol (Figure 2.10). Furthermore, worms fed heat-killed bacteria dispersed 
more that those fed live food, with or without ethanol. It is therefore it is not possible to discern 
whether or not they roamed away from ethanol in the presence of food because of an interaction 
between bacteria and ethanol generating an aversion substance. These results are consistent with 
the worms being neophobic, dispersing from novel environments. It could also be explained, 
however, by an in ability for the worms to recognise heat-killed OP50 as a food source.  
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Figure 2.10. Dispersal assay with heat killed OP50. 
15 adult worms were placed on live OP50 (Alive) or heat-killed OP50 (Dead) and on plates containing  
50mM ethanol (+E) or left untreated for 10 min. Dispersal rate from food was measured at 1 min 
intervals. Points represent mean dispersal rate. Control N = 10, Ethanol N = 10. Error bars represent ± 
S.E.M. 
2.3.3.2  Worm dispersal on OP50 incubated in ethanol  
Separate to the experiment with heat killed OP50, bacterial food was either pre-treated with 
50mM ethanol or not treated (Figure 2.11). The food was then transferred to a plate containing 36 
 
or not containing 50mM ethanol. This was rationalized to allow food pre-treated with ethanol 
and transferred to a non-ethanol plate would cause worm dispersal if it was an indirect effect of 
the bacteria. Conversely if there was no dispersal then it would indicate no involvement of the 
bacteria, and may either be due to the environment or a direct affect. 
Bacteria transferred after pre-treatment showed no differential effect on worm dispersal, 
whereas bacteria that was not pre-treated with ethanol but had ethanol present in the test plate 
showed worm dispersal consistent with previous paradigms. This result points to the bacteria 
not being responsible for any dispersal and indicates either an environmental or interaction 
driven response. 
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Figure 2.11. Dispersal assay with transferred OP50. 
15 adult worms were placed on transferred OP50 either pre-treated with 50mM ethanol (Et OP50) or 
left untreated (CON OP50) for 10 min. 15 adult worms were also placed on transferred OP50 left 
untreated to plates that contain either 50mM ethanol (Et Plate) or no treatment (CON plate).  
Dispersal rate from food was measured at 1 min intervals. Points represent mean dispersal rate. 
Control N = 5, Ethanol N = 5. Error bars represent ± S.E.M. 
The results indicate that there may be some behavioural response to ethanol intoxication, 
although this still needs to be separated from the environmental cue. The next step is to see if 
the response remains in the presence of a pre-condition treatment with ethanol to the worms. 
2.4  Discussion 
The results show that ethanol mediated behaviour can be modelled in the organism C. elegans. 
Treatment of ethanol at high concentrations shows a major depression in locomotion associated 37 
 
with a reduced ability to reach a food reward after 2 hours. This affect is not seen at 
concentrations of ethanol less than 150mM. Removing worms from ethanol causes a withdrawn 
state which presents itself as a reduction in locomotion greater than that of control worms but 
not as great as ethanol intoxicated worms. The withdrawal response seen with longer 
conditioning times is that of a ‘separate’ response, and not of any lingering residual effect of 
alcohol still present in the worm. As withdrawal state worms show an improvement in race 
outcomes when reintroduced back to ethanol, it would not be expected in worms intoxicated 
with a reducing exposure to ethanol after removal. A withdrawn state can be partially rescued 
(“relief”) in worms by treatment with a low concentration of ethanol, (Mitchell, unpublished 
data). Although not seen in these results, worms show an increased ability to make the food 
reward after 2 hours compared to withdrawn worms. It is likely that a conditioning time of 6 
hours is not sufficient to produce a significant difference between withdrawn and relieved states. 
Increasing conditioning length to 12 or 24 hours should be able to distinguish responses. This 
may also be the case for worms that have been chronically exposed to ethanol to develop 
tolerance. No significance is seen between worms on chronic exposure to ethanol and those who 
have been acutely treated. By increasing the time conditioned in ethanol it should separate the 
responses so that tolerant worms are significantly different to acutely treated worms.  
Looking at the pharyngeal pumping off and on food there seems to be a dose dependent 
inhibition with increasing ethanol concentrations reducing the pumping rate. This may be time 
dependent as early time points suggest a possible stimulatory affect. Looking at dispersal from 
food worms again show an increased rate of dispersal with increasing concentrations of ethanol. 
This does seem to be limited by the ability of ethanol to inhibit locomotion. It is still unclear as 
to why the worms disperse from food, although early indication point to a non-bacterial food 
dependent mechanism. It is interesting to note that heat-killed food also causes dispersal 
behaviour similar to ethanol treatment. It is likely that the environment is playing a role in food 
dispersal, with changing of food type or culture background causing an aversive response; 
neophobia. Both sets of experiments warrant further investigation. 
Modelling the behavioural effects of ethanol in C. elegans allows an investigation into the 
genetic and molecular determinants underpinning these behaviours. By studying the effects of 
genetic and pharmacological manipulation on the different behavioural states, the molecular 
targets of ethanol can be discovered. This will be the experimental method used to look at other 
aspects of C. elegans ethanol biology in later chapters. 
2.5  Future Work 
Whilst the behaviours under low and high ethanol intoxication and on ethanol withdrawal are 
clear further work needs to be done to significantly identify the differences in relief and 
withdrawal and tolerance and intoxication. Increasing the ethanol conditioning time may 38 
 
significantly separate these behaviours. Whilst these methods are becoming established we can 
use them to test and differentiate potential genetic targets for modulating the ethanol 
behavioural paradigms. Whilst the worm race paradigm offers a robust assay for understanding 
how ethanol works at acute and chronic treatments with relatively high dose ethanol 
concentrations, it is limited to using a population of worms. Future work should also focus on 
creating a sound paradigm dependent assay to use on individual worms.  
It is important to define the dispersal response to ethanol as a function of behavioural change 
due to ethanol or environment. Pre-exposure to an ethanol source should clarify whether the 
response is a reaction to environmental change or a direct effect of ethanol on behaviour such as 
an increase in speed or inhibition of turns. Examining the effect of early exposure should also be 
a priority during food absence as it appears that there may be a slight increase in pumping rate 
during the first 10 min that is unaccounted for on 150mM ethanol treatment. Existing 
experiments failed to pick up this response as worms were being treated with ethanol prior to 
absence from food.  
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3  Bioinformatic Identification of Genes Involved In 
Ethanol Response 
3.1  Introduction 
The need to standardise data stems from the overwhelming variation in recording and analysing 
different variables. This problem is particularly pronounced in biology because of the 
complexity of the information and the ideas that are portrayed (Soldatova and King, 2005).By 
categorising information by certain defined criteria, it is possible to overcome the potential 
problem of analysing data from different sources (Thomas et al., 2007). The work done on how 
ethanol mediates its control over behaviour is vast in its scope and multifaceted in its evidence. 
By integrating this data into a database using consistent annotation practices, it is possible to 
analyse the whole rather than the sum of its parts. In this chapter, strictly defined information 
from articles on the molecular mechanisms of ethanol actions from across 5 species has been 
compiled in a controlled format for analysis. Combined with the Gene Ontology database 
information there is approximately 3500 records of evidence for over 900 biologically important 
molecules implicated in the action of ethanol within an organism. Information on treatment 
type, duration and ethanol concentration are also available for a number of records.  
3.1.1  Ontologies 
An ontology is a system of controlled vocabulary to allow organisation and retrieval of related 
information. The idea of an ontology is to define a specific vocabulary for information such that 
it cannot vary within a certain criteria, and is therefore not open to multiple interpretations. It 
also aids in the integration of new information and the search and retrieval of related 
information by automated processes (Rubin et al., 2008). The number of different ontologies in 
the public domain is increasing, which can make linking information more difficult. Not all 
ontologies that are created will follow the guidelines of others, including the use of controlled 
vocabularies. When two or more ontologies overlap in function, careful consideration needs to 
be made regarding the information to be mapped onto the ontology before selecting a particular 
ontological system in preference to another.  
The use of an ontology ties in with the storage of information in databases. Often the ontology is 
used as a way of management and automated searching for a particular database. This is how 
the ontology system will help search and filter information from the ethanol database. Having 
an ontological based system also allows information to be easily searched or analysed in a high 
throughput manor (Beissbarth, 2006) 40 
 
3.1.1.1  The Gene Ontology (GO) 
The Gene Ontology (Ashburner et al., 2000) is the archetype biological ontology database, 
which maps the gene products of different species with information regarding three major 
components; cellular component, biological process and molecular function. A gene product is 
related to other gene products by its local within a cellular compartment, its process within that 
compartment and the molecular function of that gene product. These are mapped hierarchically 
for each gene in the form of parent-child relationships linked by identifiers to the relationship 







These relational identifiers allow information that is linked to be pulled out at any number of 
levels and to map down to the information that is related. This is a very powerful way of 
representing data and used by many ontologies.  
In addition to being used to select candidate genes, GO has been integrated into the ethanol 
target database to permit queries using these pre-existing terms. 
3.1.1.2  The Evidence Code Ontology (ECO) 
Another important type of information that needs to be controlled is the type of change that is 
observed within the biological organism due to the ethanol exposure. This problem depends on 
the type of information disseminated, as different biological molecules vary in different ways as 
well as the way in which they were measured. A good start to defining the evidence is to say 
what is happening and how it was inferred. We use the Evidence Code Ontology (ECO) 
(Evidence Code, 2008) for the controlled vocabulary discussing how the evidence was inferred.  
3.1.2  Molecular targets of ethanol 
The information and data available on the responses to ethanol is overwhelming. Many different 
organisms, treatment methods and analysis have been used to characterise ethanol mediated 
behaviour and pathology. Handling the data with such a variety is a difficult process and is not 
made easier by the lack of an integrated resource for data mining. The aim of this investigation 
is to create a universal database which incorporates pre-existing information and allows further 
integration of new information such that data can be searched, queried and filtered for analysis. 
To ensure a set standard with information integration, data is stored according to ontological 41 
 
design by which variation and redundancy is minimal. Several common pathways that respond 
to ethanol are conserved between species and are highlighted in section 1.4. 
Because of the profound effect that ethanol has on the central nervous system a large chunk of 
the research in to the molecular mechanisms controlling behaviour have focused on classical 
neurotransmitter systems and intracellular signalling cascades. These make up the majority of 
the research articles that form the base of the databases dataset.  
3.1.3  Homology mapping 
Part of the motivation of this work is the translation of observations from one organism into 
other organisms for further analysis. Of particular interest here is the relationship between 
known ethanol targets in humans and model organisms, in particular C. elegans. By recording 
specific protein UniProt accession numbers, molecules from this database can be mapped on to 
homologues from other species. Of particular interest for this analysis are putative orthologues – 
gene/proteins that are related by a speciation event (i.e. shared a single common ancestral gene 
in the common ancestor of the two species being compared).  
3.2  Methods 
3.2.1  Source data  
Data was gathered from 114 review articles dated from 2006 – 2009. Third party databases are 
queried for ethanol responsive proteins. Review articles obtained by keyword searches through 
the PubMed database. Articles are included based on the organism; Homo sapiens, Rattus 
Norvegicus, Mus musculus, Drosophila Melanogaster and Caenorhabditis elegans. 
3.2.2  Database design.  
The database was created using Microsoft Access 2003. Data is stored in nine Tables (Table 
3.1) with a single main Input table storing the primary data (Figure 3.1). In addition to a unique 
entry identifier (“ID”), this table has fifteen input fields (Table 3.2). The Molecule table lists all 
the molecules (including UniProt Accession number where possible) that are currently 
associated with ethanol response, with the original name given in the study in the Input table. 
3.2.2.1  Ontologies 
Biological ontologies are used in this work to control the vocabulary of the input data as a way 
of data management, and to facilitate automated searching of terms. This database makes use of 
the Evidence Code Ontology (ECO) and Gene Ontology (GO) (Ashburner et al., 2000). ECO 
was used to control the terms used in the database, while GO was used to define some of the 
source data (see 3.2.1). 42 
 
3.2.2.2  Molecules 
To limit duplication and confusion, genes and proteins were converted to a “Common name”, 
linked where possible to an unambiguous UniProt accession number. Chemicals were linked to 
the PubChem database accession numbers which are unique from the UniProt accession 
numbers.  
3.2.3  Orthology mapping 
Orthology mapping was performed by Dr Richard Edwards. Ensembl version 60 (accessed 
2/12/10) was used to download predicted orthology relationships between the five main 
organisms in the database: Human, Mouse, Rat, D. melanogaster and C. elegans. PICR was 
used to map UniProt accession numbers from the ethanol database onto Ensembl gene 
identifiers. These links were used to map all possible proteins from the database on to human 
proteins for network analysis and visualisation.  
3.2.4  Human network visualisation 
Orthology-mapped human proteins were visualised as a set of hyperlinked web pages using 
HAPPI (http://www.southampton.ac.uk/~re1u06/software/happi/index.html) for further data 
exploration. These pages can be accessed at: 
http://www.southampton.ac.uk/~re1u06/research/bendb_html/. 
3.3  Results 
The original search for review articles generated a list of 113 articles. This dataset was narrowed 
down based on target organism, journal availability and language, to focus only on reviews 
focused on the specific action of ethanol in a molecular context between 2006 and 2009. For 
humans and rodents the articles were all review based whilst there were too few articles for flies 
and worms to do this, and thus the worm and fly data is from non-review articles. Articles on 
dual ethanol and burn treatment, cosmetics and ethanol manufacturing were excluded as non-
relevant.  
The database is an ongoing construction and the results presented here are best considered as a 
pilot study. In total, there are 3472 separate entries from across the five different organisms. 
There are 915 different proteins from these entries. These were gathered from 66 review articles 
and The Gene Ontology database query. The database includes the Evidence Code Ontology for 






Figure 3.1. Main databases tables and relationships. 
Descriptions of tables and fields are given in text, Table 3.1 and Table 3.2. 
 
 
Table 3.1. Ethanol database tables. 
Table  Description  Entries
1 
INPUT  Main entry table  3472 
Organism  Experimental organism  6 
Molecule  Molecule ID to common name and text description mapping  992 
Exposure_Type  Exposure Type ID to text description mapping  5 
Exposure_Method  Exposure Method ID to text description mapping  4 
Exposure_Length_Unit  Description of distinct exposure units used  8 
Evidence  OBO Evidence Ontology terms  148 
Change  Phenotypic change ID to text description mapping  93 
Source_Status  Source status ID to text description mapping  3 
1. No. entries in table. 
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Table 3.2. Overview of fields in main database table. 
Field  Description  Values
1 
Molecule  Protein, gene or other molecule affected  992 
Original_Name  Molecule name given in source paper  902 
Organism  Experimental organism included in the literature  5 
Tissue_Type  Tissue implicated in the ethanol response as defined by 
the literature 
110 
Cell_Type  Cell type implicated in the ethanol response as defined 
by the literature 
45 
Exposure_Type  Nature of ethanol exposure (chronic, acute etc.)  5 
Exposure_Length_Value  The numerical value of the exposure time used for 
ethanol treatment 
n/a 
Exposure_Length_Unit  Units of length of ethanol exposure  7 
Exposure_Conc  Concentration of ethanol used in the experiment  119 
Exposure_Method  Nature of exposure method (in vitro, in vivo etc.)  4 
Change  Observed phenotypic (biochemical or behavioural) 
change associated with ethanol exposure and the 
molecule input 
93 
Evidence  OBO evidence code ontology (ECO) term  53 
Source  Source PubMed ID, or the organism specific database 
source ID for third party database gathered information  
1525 
Source_Status  Database curation field (read or unread literature 
source) 
3 
Relevance  Brief text input to describe inclusion of a particular 
source or third party database search 
n/a 
1. No. distinct values in database. 
3.3.1  Data entry 
The aim of the database was to include a comprehensive summary of each piece of evidence, 
taken from a third party perspective that, in addition to providing a useful overview, would 
allow easy querying for specific information by users.  
3.3.1.1  Molecules 
In order to maintain comprehension and uniformity the data was limited to several variables 
which were identified before and during data entry. As the dataset was selected with a 
preference for molecular evidence; genes and proteins were the primary focus. This later 
expanded to include other molecules and chemicals, either intrinsic biological chemicals or 
externally derived pharmacological agents. To limit duplication and confusion genes were 
converted to proteins and the common name linked to the UniProt accession number used to 
identify the molecule. The chemicals were linked to the PubChem database accession numbers 
which are unique from the UniProt accession numbers. This process is not without caveats, as 
genetic mutants are not always a direct effect on the protein and thus linkage between what was 
actually studied and information in the database may be misinterpreted. To overcome this 
information about the change and the type of evidence, such as an up-regulation in an 
experiment from transcript levels were also recorded so that such information is not lost.  45 
 
There were also problems associated with multiple subunit proteins and complexes, which are 
referred to as single entities in the mined information, but are recorded as separate proteins in 
the UniProt accession database. This was overcome by either citing the alpha subunit in 
homomeric complexes or not recording an accession number in multimeric complexes.  Indeed 
this problem extended into data interpretation whereby authors would refer to a single protein as 
a specific entity, when several isoforms were present with specific functions and local. This 
again was overcome by either inferring subunit specificity in the dataset with clarification or 
deduction from the article at hand or simply not recording the information because of 
ambiguity. In addition this information was aided with the original author nomenclature 
recorded in the database such as to reduce error, or to correct at a later date when presented with 
further information. 
3.3.1.2  Source organisms, tissue and cell type 
Input data was restricted to that for one of five pre-selected organisms. Information from other 
organisms were rejected and not input into the database. If the organism information was not 
clear, as was the case with some of the papers on rodent studies, then the information was also 
not incorporated.  
The tissue type and cell type were recorded also. These were not a problem except in one case 
where there was a mixed rat/human cell line used. This was input but did not have an organism 
input into its respective table field.  
3.3.1.3  Treatment details 
The treatment type tried to identify which type of treatment paradigm the research evidence was 
investigating. It was restricted to acute, chronic withdrawal and undefined. It was recorded if the 
publication specified the interest area, and was not assumed from the treatment duration. This 
was to avoid confusion between standardising between publications. Any assumptions that can 
be made on the does and time can be made from the raw data, where available, as to which 
paradigm in which organism was used. This is analogous to the recording of the proteins 
common name whilst still recording a unique protein accession number.  
The value and duration of the treatment course were recorded in separate fields as to keep 
numerical and text data separate. Values were overlapping, e.g. 24 hours and 1 day, as to keep 
data entry quick, as conversions between values would have been lengthy. This process can still 
be applied later, which also makes examining individual records simpler at a later date. 
Treatment duration always focuses on the length of ethanol exposure. This is true for 
withdrawal treatment paradigms, but is complicated by the duration from ethanol before 
reintroduction in complex behavioural paradigms. Duration of abstinence is not recorded. For in 
utero based experiments assessing the risk of prenatal exposure to ethanol, the duration of 
alcohol was standardised to 21 days, the average period of gestation for the rodents. For human 46 
 
in utero studies, no time data was included. Where ethanol concentration was given in the paper, 
it was recorded as described. Values were not standardised, and because of the complex nature 
of the values the data was stored as a text field. Some of the values were given as a 
concentration range, to avoid unnecessary data duplication. 
3.3.1.4  Types of experiment 
The method is a brief indication of the type of experiment done. The majority were in vivo 
experiments directly on an organism. Cell culture experiments were recorded as in vitro, 
although strictly speaking they are ex vivo. In utero describes the experiments done on ethanol 
exposure to pre-natal organisms. In silico was used to annotate which data was pulled from 
online databases. The experiments themselves may not be computer generated.  
3.3.1.5  Ethanol effects 
The change is a large set of different outcomes as a result of scientific scrutiny of a particular 
molecule. The list of changes was decided on from the information provided by data entry and 
was a rolling and adapting process of change type entry. Initial focus was placed purely on the 
proteomic level of change, with the hope of simply including up and down regulated molecules. 
This was quickly replaced by a need to include change not direct attributable to a regulation 
state of a single molecule, and started to incorporate more complex changes and phenotypes. 
The final adaptation was to include behavioural phenotypes of particular organisms under 
controlled situations. This has complicated the implications of how this data is analysed. 
3.3.1.6  Evidence Code Ontology 
The evidence field is based on the ontological system devised by the evidence code ontology. It 
lists a large number of evidence types in a hierarchical system to encompass the majority of 
molecular biology. It is this system that has been used to populate the evidence field. Not all 
evidence types were covered in the ontology, those that were not available as options were 
either excluded or labelled as a more baseline identifier.  
3.3.1.7  Data sources 
The source of the evidence was included as a PubMed ID pointing to the reference article. The 
data obtained from the GO database was kept in its original form of a unique organism database 
reference ID. Some of these were multiple articles separated by a pipe, they were not duplicated. 
The paper was labelled as read or unread to track changes in data entry. A final memo line was 
included to give an indication of why the original source was included in the dataset, again in 
order to track changes in data entry and database management. 
3.3.2  Additional visualisation 
As a resource for further investigation, orthology-mapped human proteins were visualised as a 
set of hyperlinked web pages using HAPPI (http://bioware.soton.ac.uk/software/happi/) for 47 
 
further data exploration. These pages can be accessed at: 
http://bioware.soton.ac.uk/research/bendb/. 
3.4  Discussion 
The current work represents a pilot study, with further work needed to complete information 
entry into the database. Integration of information in to the database was the slowest, rate 
determining step. Manual data mining from the reference articles was an arduous task 
complicated by the variation in information presentation and nomenclature. Information 
gathering and input is a time- and labour-intensive task, which may benefit from a more 
community-driven “wiki” approach in future. Additional developments in the realm of text 
mining might also be of benefit to this project; the current setup can incorporate data with 
different degrees of confidence, which might enable to the visualisation of larger trends. Such 
data sources might also help overcome the inevitable ascertainment bias that arises when relying 
on review articles that have invariably been prepared with certain conscious or subconscious 
biases. 
The current database structure is functional but could benefit from the integration of further 
biological ontologies; these should allow better visualisation of information output and 
advanced query function. As information was added to the database, the design itself had to be 
updated. Although undesirable, and potentially creating some inconsistency in the data stored, 
such changes are inevitable in this kind of project. It also became apparent that the degree of 
detail hoped for in terms of both ethanol treatments and effects was often absent, particularly 
from review papers. Given the difficulty in measure precise concentrations or durations for 
certain experiments, the inherent ambiguities and sometimes subjective reporting associated 
with behavioural responses, and the difficulty in conclusively linking responses to specific 
molecules, these limitations were to be expected but the scale of them was still a little 
disappointing. 
3.5  Future Work 
To fulfil the initial goals of the database, data from additional papers needs to be added to the 
database. Once all the information has been input then effort can be concentrated on data output 
and visualisation. The database requires the use of several ontological structures to manage 
information. One goal for future work is to integrate the ontologies into the structure of the 
database so that information can be queried and filtered through the ontological hierarchies. 
Another aim is to create a database front end so that information can be retrieved by users or so 
that information can be both retrieved and integrated by users.  48 
 
4  The Unfolded Protein Response and Ethanol 
4.1  Introduction 
4.1.1  Ethanol as an agent of stress 
Stress is an important component of the psychological and molecular response to ethanol. 
Ethanol intoxication, particularly at higher doses, engages regimes that are recognized as 
cellular stresses. Classic among these are the heat shock systems in which cellular stress of heat 
shock induces several molecular pathways including HSP-90, 70 60 and 40 and a number of 
small heat shock proteins. These routes are often engage additionally as response to cellular 
stressor including oxidative stress protein misfolding and toxicological activation. This is 
recognized by several studies that identify robust stress responses upon ethanol intoxication. 
Less is known if the reactive responses that underlie withdrawal and tolerance engage such 
pathway. Nonetheless, the induction of these pathways during the intoxication regimes that lead 
to withdrawal and tolerance makes this formally possible. Indeed, the Heat shock responses are 
often associated with protective pathways that operate during preconditioning protection. These 
stress pathways are known to modulate cellular stresses of the nervous system and potentially 
underpin cells and pathways implicated in ethanol effects. One such pathway that is poorly 
understood with respect to ethanol is the Unfolded Protein Response (UPR).  
4.1.2  The Unfolded Protein Response (UPR) 
The UPR is an evolutionary conserved mechanism for the homeostatic response to an increase 
in perturbed secretory and transmembrane proteins. Increases in protein load, dysregulation of 
calcium levels, altered endoplasmic reticulum redox environment, malfunctioning protein 
degradation and immune insult all trigger the UPR. An array of chaperone proteins, proteins 
linked to the secretory pathway and scavenging proteins all work to normalise stress condition 
within the endoplasmic reticulum. If ER stress remains unaltered then programmed cell death is 
triggered. Chronic ethanol conditioning has been shown to induce an UPR in several organisms 
including Caenorhabditis elegans. It is unclear, however, whether ethanol triggers an unfolded 
protein response at concentrations that cause behavioural responses to ethanol, and whether the 
UPR modulates these behavioural phenotypes.  
The UPR was first recognised as an adaptive response to nutrient deprivation and misfolded 
protein load in the organism Saccharomyces cerevisiae (Kozutsumi et al., 1988). Identification 
of the processes triggering the UPR, the proteins involved in regulating transcriptional events 
and the identification of a consensus regulatory sequence upstream of target genes allowed for 
the characterisation of this separate response (Cox et al., 1993; Cox and Walter, 1996; Dever et 
al., 1992; Yoshida et al., 1998). Parallel work identified and characterised the S. cerevisiae 49 
 
pathway in mammalian cells and demonstrated the conservation and importance of the UPR 
(Harding et al., 1999; Haze et al., 1999; Wang et al., 1998).  
Typically the UPR response is triggered by an increase in misfolded protein load within the ER 
(Kohno et al., 1993); sequestering chaperone proteins and straining the protein degradation 
process. An increase in misfolded proteins can be caused by a perturbed folding system, 
glycosylation system or ER homeostasis mechanisms which act to keep the endoplasmic 
environment as favourable to protein folding as possible; such examples include calcium levels 
(Bonilla et al., 2002; Hojmann Larsen et al., 2001) and redox conditions (Trotter and Grant, 
2002). Aggravation of endoplasmic reticulum associated degradation (ERAD), the process of 
removal and destruction of misfolded proteins, also triggers the UPR (Mouysset et al., 2006; 
Sasagawa et al., 2007; Tcherpakov et al., 2008). Other triggers of the UPR include infection 
with pathogens (Bischof et al., 2008; Haskins et al., 2008), nutrient deprivation (Fernandez et 
al., 2002a; Kozutsumi et al., 1988), heavy metal toxicity (Liu et al., 2006; Yokouchi et al., 
2007) and perturbed ER protein trafficking (Higashio and Kohno, 2002; Sato et al., 2002). 
In addition to moderating environmental responses components of the UPR are constitutively 
activated at basal levels to help control protein synthesis, development and cell differentiation 
(Sharkey et al., 2008; Sugiura et al., 2009). Failure of the UPR to maintain normal levels of 
misfolded proteins activates apoptosis (Hetz et al., 2006). The UPR is also seen as an important 
survival switch for tumourgenesis, allowing the extended life of cancer cells beyond detrimental 
conditions.  
The unfolded protein response has also been implicated in the physiological pathogenesis of 
several diseases including chronic alcohol consumption, playing an important role in the 
development of liver damage, possible neurodegeneration, glucose/insulin dysregulation and 
alcoholic cardiomyopathy. Work done in the model organism C. elegans has shown a link 
between the UPR and ethanol exposure (Kwon et al., 2004; Uccelletti et al., 2004). C. elegans 
presents a useful platform for studying the effects of ethanol on the UPR because of the genetic 
tractability of the organism and the wealth of work already acquired on both ethanol exposure 
and the unfolded protein response. This review outlines the current knowledge of the unfolded 
protein response, similarities in C. elegans, the link between ethanol and the UPR and the use of 
C. elegans to dissect the role of the UPR in ethanol consumption. In addition the link between 
ethanol and the unfolded protein response in C. elegans is investigated, exploring the role the 
UPR may have in mediating the behavioural responses to ethanol. 
4.1.3  Overview of UPR activation in humans/mammals 
Primary initiation of the UPR is through the increased binding of Binding immunoglobulin 
Protein (BiP) to unfolded proteins in the ER (Fig 4.1). Binding of BiP to unfolded proteins 
sequesters it away from its alternate residency on ER membrane bound proteins 50 
 
Serine/threonine-protein kinase/endoribonuclease 1 (IRE1ʱ), Cyclic AMP-dependent 
transcription factor 6 (ATF6ʱ) and PRKR-like endoplasmic reticulum kinase (PERK) whose 
activation are repressed by bound BiP (Bertolotti et al., 2000; Sommer and Jarosch, 2002). 
These three transmembrane proteins represent the three main pathways of the UPR; although 
there is current work to highlight the less well understood areas of UPR activated pathways 
(Caruso et al., 2008).  
Upon increase in ER misfolded proteins BiP dissociates away from membrane bound PERK, 
binding the misfolded proteins. Dissociation of BiP then allows for subsequent dimerisation, 
and trans-auto phosphorylation of the membrane bound PERK protein (Ma et al., 2002). 
Activation of PERK initiates a kinase function in which it phosphorylates serine residue 51 on 
eukaryotic translation initiation factor 2 subunit alpha (eIF2ʱ) (Harding et al., 1999). 
Phosphorylation of eIF2ʱ allows for an attenuation of general protein translation through 
disruption of the 43S translation-initiation complex (Kimball et al., 1998), and an initiation of 
selective translation of UPR regulated transcripts. This may be mediated through internal 
ribosomal entry sites (IRES) or upstream open reading frames (uORF) within the 5’-
untranslated region of specific mRNAs (Fernandez et al., 2002b; Lee et al., 2009). In addition 
PERK can also phosphorylate the transcription factor Nrf2, disassociating Nrf2 away from a 
complex with Keap1, and activating transcription of proteins involved in redox homeostasis 
(Cullinan and Diehl, 2004; Cullinan et al., 2003). 
The release of BiP from membrane bound IRE1ʱ also allows for dimerisation and trans-auto 
phosphorylation, activating its cytosolic domain which has ribonuclease activity (Tirasophon et 
al., 2000). The ribonuclease activity of IRE1ʱ allows it to cleave the mRNA transcript of xbox-
binding protein (XBP1). IRE1ʱ ribonuclease removes a 26 nucleotide intron from the mRNA; 
causing a frame shift in the XBP-1 transcript and a change in size from 261 to 376 amino acids 
(Yoshida et al., 2001). IRE1ʱ cleavage of xbp1 mRNA leads to selective translation by the 
aforementioned phosphorylated eIF2ʱ. XBP1 is a potent transcription factor that binds the 
consensus sequence CCAATN9CCACG, known as the ERSE sequence. ERSE is located 
upstream of many of the UPR regulated genes involved in protein folding, chaperone function 
and ER homeostasis (Yoshida et al., 1998). XBP1 may also bind the unfolded protein response 
element (UPRE) [TGACGTGG/A], which also lies upstream of UPR associated proteins (Wang 
et al., 2000; Yoshida et al., 2003). IRE1ʱ may also use its ribonuclease activity to degrade 
specific mRNAs, relieving the strain on peptide folding and translation (Hollien and Weissman, 
2006). 
ATF6ʱ release from the ER membrane is promoted by BiP dissociation. Upon release ATF6ʱ 
relocates to the Golgi apparatus where it undergoes cleavage and processing by two membrane-
bound proteases; S1P and S2P which remove an N-terminal 50kDa peptide sequentially. This 
cleavage allows p50ATF6ʱ to bind the CCACG portions of the ERSE and ERSE II sequences 51 
 
[ATTGG-N-CCACG] with the help of NF-Y binding the CCAAT region, promoting 
transcription of UPR associated genes (Kokame et al., 2001). 
The promotion of UPR specific genes is associated with an increased need to allow for protein 
degradation through ERAD, protein secretion, amino acid synthesis and cell cycle associated 
proteins. A great number of proteins are differentially regulated and have been characterised in 
several organisms. 
4.1.4  The UPR and disease 
The unfolded protein response is a complex mechanism for maintaining cellular homeostasis 
and is prone to disruption and malfunction. A wide range of insults can trigger the UPR, making 
the likelihood of its involvement in disease pathology quite high. Some of these triggers and 
diseases are explored in more detail below.  
4.1.4.1  Hyperhomocysteinemia  
Hyperhomocysteinemia and lipid metabolism perturbations are both risk factors for 
atherosclerosis. Hyperhomocysteinemia can trigger the UPR (Outinen et al., 1999) and lead to 
problems in lipid regulation and cholesterol synthesis (Hamelet et al., 2007; Werstuck et al., 
2001). Hyperhomocysteinemia also contributes towards liver steatosis, large vacuoles of lipids 
developing within hepatic tissue. Homocysteine is believed to regulate lipid synthesis and 
scavenging through the protein SREBP and the UPR (Kaplowitz and Ji, 2006).  
Excess exogenous and endogenous sources of saturated fatty acids have been shown to trigger 
the UPR in S. cerevisiae (Pineau et al., 2009). There may be a link between the UPR and the 
pathology of diseases associated with a high fat diet, such as cardiovascular disease and 
diabetes. It has been shown that cholesterol overloading has the ability to induce the UPR, and 
that atherosclerotic plaque growth and macrophage apoptosis may be an impact of this (Devries-
Seimon et al., 2005; Tabas et al., 2007). The apoptosis regulator CHOP is thought to play a 







Figure 4.1. The unfolded protein response. 
A. Repressed state of the UPR. Proximal sensors ATF6, PERK and IRE1 remain inactivated on the 
endoplasmic reticulum membrane whilst bound to the ER chaperone BiP. Increases in misfolded 
proteins, red shapes, promotes BiP disassociation from membrane proteins. B. Activation of the 
unfolded protein response. Increases in misfolded proteins cause the disassociation of BiP away from 
the proximal sensors on the ER membrane. IRE1 and PERK dimerise and auto-phosphorylate on 
activation. IRE1 can then cleave xbp-1 mRNA. PERK phosphorylates the transcription factor Nrf2 and 
translation control protein eIF2α, purple circles. eIF2α attenuates general translation whilst activating 
translation of UPR specific transcripts such as ATF4 and XBP1. ATF6 translocates away from the ER and 
is cleaved by S1P and S2P proteases on the Golgi. ATF6 50kDa fragment then activates transcription 
with NF-Y. Transcription activates UPR specific genes controlling ER homeostasis and protein folding 





4.1.4.2  Diabetes 
Diabetes is caused by a lack of, or lack of response to, insulin. Insulin is secreted from β-islet 
cells to increase cellular glucose uptake. Long and short term changes in glucose availability 
and subsequent insulin demand require plasticity in the β-cells. This demand is placed on the 
ER for maintaining efficient levels of insulin peptide for secretion. Any changes in the UPR 
homeostasis mechanism may lead to dysfunction. Wolcott-Rallison syndrome is a condition in 
which sufferers develop type 1 diabetes, growth retardation and neurological disorders (Iyer et 
al., 2004). It has been mapped to mutations in the PERK gene (Delepine et al., 2000). The 
inability of PERK to function as an activator of translational repression leads to a continual 
translation of peptides despite the inability to fold them. This activates apoptosis and leads to β-
cell death and diabetes (Zhang et al., 2002). Interestingly mice with eIF2a S51A mutations, the 
phosphorylation site in response to stress, also show diabetic phenotypes on a high fat diet. 
Homozygous mice die in embryogenesis due to β-cell deficiency whilst heterozygotes are prone 
to obesity and developing type 2 diabetes (Scheuner et al., 2001; Scheuner et al., 2005).In 
addition UPR markers have been shown to be upregulated in obese, type 2 diabetic patients 
(Boden et al., 2008). 
Insulin resistance may be mediated through converging pathways with ER stress. Insulin 
receptor (IRS1) gets phosphorylated by JNK (Aguirre et al., 2000; Lee et al., 2003). JNK is a 
target of IRE1 mediated activity on ER stress (Urano et al., 2000). Hyperphosphorylated PERK 
and eIF2ʱ have been found in the liver and adipose tissue of obese mice, and have been shown 
to induce JNK activation (Ozcan et al., 2004). Activation of the JNK pathway increases insulin 
resistance.  XBP1 deficient mice develop similar phenotype to type 2 diabetes. These findings 
implement the UPR in the development of Type 1 and 2 diabetes and a link to obesity. 
Seipinopathy describes a range of neurological disorders caused by the misfolded, ER resident, 
glycoprotein Seipin. Seipin is a transmembrane protein of unknown function (Lundin et al., 
2006). Mutations in the N-glycosylation regions of Seipin can lead to misfolding and 
aggregation (Windpassinger et al., 2004). ER stress may be the process which eventually leads 
to neuronal cell death. Mutant protein expression induces apoptosis, and expression of mutant 
Seipin causes upregulates UPR markers (Ito and Suzuki, 2007). They also form cell inclusion 
bodies in vitro (Ito et al., 2008), although this has not been demonstrated in vivo.  
4.1.5  The UPR in C. elegans  
Although the components and regulation of the unfolded protein response remain highly 
conserved between organisms, there are differences that are specific to C. elegans and processes 
that have been further examined using this model organism. These extra details are addressed in 




Figure 4.2. The UPR network of protein interactions in C. elegans. 
Schematic network representation of the events controlling the UPR based on evidence from C. 
elegans studies. Proteins given in blue circles with black (non-lethal on KO) or red (lethal on KO) 
outline. Mitochondria highlighted in pink, nucleus in light blue, Golgi in yellow and ER in green. Dotted 
line representative of membrane lipid bilayer. Arrows indicative of interaction events. Blue rectangles 
in nucleus indicate transcription events. Scissors indicate splicing or modification event.   
4.1.6  Endoplasmic Reticulum-Associated Degradation (ERAD)  
On activation of the UPR one of the initial responses is to remove and recycle the offending 
misfolded proteins from the ER. The process of ERAD works to remove proteins from the ER 
by retrotranslocation before targeted destruction by the proteasome. Misfolded proteins are 
targeted by chaperones and localised to the ER membrane where SEC61 and accessory proteins, 
such as Derlin and p97, can transport the peptide out by retrotranslocation (Vembar and 
Brodsky, 2008). Removal by SEC61 initiates targeted ubiquitination by membrane bound 
proteins such as gp78, parkin, RNF5/RMA1 and HRD1. 
The ERAD protein JNK-associated protein (JAMP) promotes proteasome localisation to the ER 
and links the removal of misfolded proteins to their subsequent destruction (Tcherpakov et al., 
2008).  JAMP is a membrane bound protein with its N-terminal in the ER lumen interacting 
with ERAD components, whereas the C-terminal remains cytosolic, associating with 
proteasome subunits RPT4 & RPT6. JAMP associates with proteasomal subunits during both 
normal and stressed conditions. Proteasome binding is negatively regulated by RNF5 
ubiquitination of JAMP (Tcherpakov et al., 2009). In addition JAMP interacts with JNK and 55 
 
modulates its activity (Kadoya et al., 2005). JAMP mutants have delayed development on 
exposure to ER stressors and are hyper sensitive to tunicamycin. Mutants also show higher basal 
levels of ER stress; similar to Sel1, Derlin and Ero1 mutants (Tcherpakov et al., 2008). 
When misfolded proteins are retrotranslocated from the ER via SEC61 they are subjected to 
ubiquitination, ready for proteasomal degradation (Kostova et al., 2007). C. elegans contain 
three E3 ubiquitin ligases HRD1, HRDL-1 and MARC-6. These are transmembrane, ring finger 
proteins that share homology to ubiquitin ligases in yeast and humans. HRD1, HRDL-1 and 
MARC-6 double and single mutants affect growth and share phenotypes that suggest a role in 
protein folding. It is believed that these proteins play a role in ERAD mediated ubiquitination 
(Sasagawa et al., 2007). Of the E3 ligases only HRD1 interacts with HSP-3 and HSP-4 (C. 
elegans homolog of BiP) and p97. C. elegans contains two homologs of p97 (cdc-48.1 & cdc-
48.2). p97 forms a homo-hexamer pore at which its N-terminal domain interacts with regulatory 
proteins (Mouysset et al., 2006). The interaction between p97, BiP and HRD1 may help 
coordinate the protein removal with targeted destruction, although the role of the homologs in 
this process remains unclear. These interactions may be of specific importance during 
development, HSP-3 is involved in intestinal development and HSP-4 in gonad formation 
(Sasagawa et al., 2007)  
4.1.6.1  UPR Stress Responses in C. elegans 
The ire-1:xbp-1 arm of the UPR is consistently needed to activate response genes to stress and 
can be seen in C. elegans to be one of the main, yet remarkably diverse transcriptional 
activators. Shen et al. looked at the changes in mRNA in UPR mutants, identifying 202 genes, 
of which 84% of these genes regulated by ire-1 and xbp-1 (Shen et al., 2005). Interestingly the 
same paper identifies a novel bZIP transcription factor CREBh, which shares homology with 
CREB and ATF family members, under the control of the ire-1:xbp-1 arm. The role of CREBh 
in response to unfolded proteins is of interest and has been discussed earlier. 
Calreticulin is a calcium ion binding protein localised in the ER and which is essential for 
normal physiological conditions. Calreticulin is upregulated on heat stress and 7% ethanol 
treatment (Park et al., 2001). Calreticulin functions to maintain protein folding and calcium 
homeostasis in the ER, and its function is partially redundant with calnexin (Lee et al., 2005). 
Calreticulin (crt-1) mutants are hypersensitive to tunicamycin, and CRT1 is induced by both 
tunicamycin and heat stress.  The promoter region of crt-1 contains two XBP1 binding sites and 
an ERSE sequence. RNAi analysis suggests that crt-1 regulates its own expression in a negative 
feedback mechanism, and in addition regulates levels of pdi-2 and pdi-3, disulfide bond forming 
chaperones (Lee et al., 2007; Lee et al., 2006). 
Calcium levels are an important factor in ER homeostasis.  Store operated calcium entry 
(SOCE) is activated on ER calcium depletion and is an essential to refill ER calcium stores and 56 
 
aide calcium signalling. Human STIM1 and STIM2 have been identified as mediators SOCE 
and function to differentially modulate calcium channels (Liou et al., 2005; Soboloff et al., 
2006). A STIM1 homolog is present in C. elegans. Efflux of calcium out of the ER can trigger 
the UPR as well as RNAi of calcium pumps that restore ER calcium levels. Knockout of STIM1 
does not trigger the UPR and is unlikely to play a role in refilling the ER calcium stores (Yan et 
al., 2006). 
Small GTP binding proteins of the RAS super-family may also have a role in ER stress. 
Knockout of SAR1 by RNAi induces the UPR. CDC42 and CRP1 are required for UPR 
activation as RNAi knockdown leads to reduced levels of ER stress on tunicamycin treatment 
(Caruso et al., 2008). CDC42 has been implemented in Golgi to ER vesicle trafficking, whilst 
CRP1 has a role in membrane trafficking in epithelial cells (Jenna et al., 2005; Luna et al., 
2002). Interaction analysis for CRP-1 using GST pull downs with mass spectrometry 
identification revealed interactions with C. elegans p97 (CDC48.1/2) ATM1, HIM6 (BLM 
homolog) and WRN. This suggests that the function of CRP-1 might be involved in 
transcriptional activation through chromatin remodelling. Mutants in crp-1, atm-1 and cdc-48.1 
all show hyper-sensitivity to tunicamycin (Caruso et al., 2008). 
The UPR may not be limited to purely ER mediated activation, and may be triggered separately 
in the mitochondria (mtUPR). The mitochondrial stress response activates genes responsible for 
chaperone and folding proteins independent from ER stress response (Zhao et al., 2002). 
Mitochondrial stress is regulated separately from ER stress by the AP-1 promoter (Aldridge et 
al., 2007). This stress response is also present in C. elegans (Yoneda et al., 2004). DVE1 and 
UBL5 are found in the nucleus of mitochondria rich cell types and are required for the 
activation of the UPR independently of ER stress. The C. elegans ClpP homolog (clpp-1) 
controls the translocation of DVE1 to the nucleus independently of UBL-5. clpp-1 RNAi 
knockout stops activation of UBL-5 and subsequent DVE1/UBL5 complex formation (Haynes 
et al., 2007). In bacteria ClpP is responsible for proteolysis of a repressor of the stress response 
(Frees et al., 2007), and it is possible that this mechanism may have been conserved in 
eukaryotic mitochondria. The activation of DVE1 and UBL5 by ClpP may represent a signal 
transduction pathway for mitochondrial protein stress. 
4.1.6.2  UPR influences on behaviour 
It is not currently clear whether the UPR influences or outputs any behavioural response, 
although it appears that perturbed pathways that activate the UPR may lead to behavioural 
changes.  
Hereditary spastic paraplegia (HSP) is an inherited neurological disorder characterised by 
spasticity in the lower limbs. The NIPA1 gene is implicated in HSP onset and disease 
progression (Rainier et al., 2003). The C. elegans homolog of NIPA1 shares ~45% identity with 57 
 
the human homolog and, importantly, shares the disease causing site giving rise to the HSP 
phenotype in humans (Zhao et al., 2008). Using mouse cells Zhao et al. were able to show 
mutant NIPA1 retention in the ER due to protein misfolding. Expression of mutant NIPA1 in C. 
elegans gave a phenotype comparable to human HSP.  Mutant worms were fully paralysed by 
day 9, with paralysis progressing from the posterior to anterior. Expression of mutant NIPA1 in 
xbp-1
-/- background produced a complete rescue of paralysis and of longevity, indicating a role 
of the UPR in the progression of this disease.   
AMPA-type glutamate receptors are one of the main types of excitory signalling components in 
the CNS. The function of these receptors relies on the correct subunit assembly and processing, 
which is mediated by the ER (Greger et al., 2007). Neurons in C. elegans require the UPR 
components to move receptor subunits through the ER.  
ire-1/xbp-1 mutations are associated with a defective localisation of GLR-1 resulting in 
increased ER retention (Shim et al., 2004). GLR-1 is required for mechanosensory neurons 
(Maricq et al., 1995), and ire-1/xbp-1 mutants are deficient in nose touch response in much the 
same way as glr-1 mutants (Shim et al., 2004). This supports the hypothesis that the UPR can 
impact processing and expression of major determinants of neuronal function and has the 
potential to respond to a modified environment and/or pharmacological inputs. 
 
4.1.7  Ethanol and the UPR 
4.1.7.1  Acute effects 
Ethanol is believed to be an inducer of endoplasmic reticulum stress and a cause of the UPR. It 
is unknown whether ethanol directly causes the UPR or triggers it as a secondary consequence 
of differential targets.   
Several studies have shown HSP4 (GRP78) the sensor of unfolded protein in the ER and an 
indicator of UPR activation are upregulated in response to ethanol treatment. These studies have 
monitored transcript expression increases on ethanol treatment. NG108-15 neuroblastoma x 
glioma cells grown in the presence of 100mM ethanol for 24 hours caused a 2-fold increase in 
the abundance of hsp-4 mRNA (Miles et al., 1994). In a follow up study the group shows that 
ethanol also potentiates an upregulation of hsp-4 mRNA by thapsigargin, tunicamycin and 
brefeldin A (Hsieh et al., 1996). Increases in hsp-4 mRNA after 100mM ethanol treatment were 
seen at 24h in SH-SY5Y cells, and in week 1 of an 8 week chronic treatment protocol. This 
increase was not observed at a protein level on acute and chronic ethanol treatment (Muhlbauer 
and Rommelspacher, 2003). Ethanol treatment of SH-SY5Y cells with 400 mg/dl over 12 hours 
showed no increase in ER stress proteins such as HSP4 and CHOP. Ethanol could however 
potentiate an ER stress response to tunicamycin and thapsigargin treatment by means of ROS 
production. Potentiation by ethanol could be lost on co-treatment with anti-oxidants (Chen et al., 58 
 
2008). Increases in both hsp-4 mRNA and protein were observed in the liver and brain of rats 
fed a 5g / kg diet, although this was not observed in rats fed 2g / kg diet (Tunici et al., 1999). 
The upregulation of HSP4 a marker for ER stress and UPR induction is likely to be induced 
with chronic, high concentration ethanol treatment. The mechanism of induction may be 
translationally regulated as whilst hsp-4 mRNA is upregulated on ethanol treatment, this affect 
is only seen at a protein level on high concentration and chronic treatment. 
Chronic ethanol use has been implicated in the pathology of several diseases through activation 
of an unfolded protein response. Hyperhomocysteinemia is a condition of increased serum 
homocysteine and has been shown to trigger the UPR on chronic alcohol feeding (Kaplowitz 
and Ji, 2006). Hyperhomocysteinemia is a risk factor in a number of disorders such as 
atherosclerosis and hepatosteatosis. Hyperhomocysteinemia is believed to play a role in lipid 
dysregulation through the protein SREBP. Triggering the UPR hyperhomocysteinemia activates 
the cleavage of SREBP through S1P and S2P, similar to ATF6. Ethanol is believed to increase 
homocysteine levels by down regulating methionine synthase. Ethanol mediated liver toxicity 
and steatosis can be prevented by supplementation of diet with betaine (Esfandiari et al., 2005). 
The conversion of homocysteine to adenosylmethionine by methionine synthase is a folate 
dependent process. ER stress may also be exacerbated by the activation of CYP2E and oxidative 
stress through ethanol metabolism and ROS generation.  
4.1.7.2  UPR, ethanol and C. elegans 
Ethanol has also been shown to trigger the unfolded protein response in C. elegans. Using a 
concentration of 7% ethanol (1.4 M) C. elegans is completely paralysed until recovery on 
treatment withdrawal, from which 50% of worms survive. Using 7% ethanol microarray data 
revealed that several groups of transcripts were upregulated; amongst them were several 
indicators of an unfolded protein response (Kwon et al., 2004). It has also been shown that 7% 
ethanol at 16°C for 6 hours is able to trigger an unfolded protein response using the reporter 
system phsp-4::GFP (Kwon et al., 2004).  
The unfolded protein response is implicated in a range of disorders and is activated on a number 
of stresses. The unfolded protein response is an evolutionary conserved mechanism for coping 
with stress which extends to the model organism C. elegans. The effects of ethanol on C. 
elegans, discussed in Chapter 1, exhibit differential behavioural responses depending on the 
method of conditioning. These are both time and dose dependent, with the severity of the 
behavioural response increasing with dose and time conditioned. Ethanol has been shown to 
induce a stress response both in mammals and in C. elegans (Kaplowitz and Ji, 2006; Pandol et 
al., 2010; Uccelletti et al., 2004). The aim of this research is to investigate whether the ethanol 
conditioning paradigms used to elicit a behavioural response also activate physiological stress 
response. If a stress response is activated whether this modulates the behavioural response to 
ethanol in C. elegans. 59 
 
4.1.7.3  Motivation for current work 
Provoked by published information and our own proteomic investigation pointing to a modified 
ER response during ethanol conditioning led us to investigate using the hsp-4 (BiP/GRP78) 
promoter linked GFP reporter array in C. elegans as a mechanism for monitoring. In addition, 
we took advantage of the established behavioural assays to investigate if the hsp-4 induced 
pathways are involved in the behavioural consequence of withdrawal. This allowed us to 
integrate aspects of existing data to test potential for new pathways to be involved in ethanol 
induced behaviours. 
4.2  Methods 
4.2.1  Nematode strains.  
As detailed in 2.2.2.2 
4.2.2  Worm preparation.  
As detailed in 2.2.2.3 
4.2.3  Escherichia coli OP50 culture.  
As detailed in 2.2.2.1 
4.2.4  Worm race assay.  
As detailed in 2.2.3.1 
4.2.5  Ethanol test.  
As detailed in 2.2.2.4 
4.2.6  UPR assay.  
Culture plates (3cm) hand poured with 4.5 ml of NGM agar and left 24h to set. Tunicamycin 
(Sigma-Aldrich) was diluted to 100x solution in DMSO before being added to molten NGM 
media plates to give a final concentration of 5 μg ml
-1 or 30 μg ml
-1. Comparative amounts of 
DMSO (0.01%) were added to molten NGM control plates. Dried plates were seeded with 50 μl 
of Escherichia coli OP50, standard nematode food, at 0.8A [OD600] and left 24h. Selected 
seeded plates were treated with ethanol (99.9%) to give final concentrations as indicated. Plates 
were left 24h for the ethanol to equilibrate across the agar. Larval stage 4, zdIs4 worms were 
separated 1 day before treatment and incubated 24h at 20°C. L4+1 day worms were transferred 
to treatment plates for 24 hours. Images were recorded using a CCD camera mounted to a 
fluorescent microscope at described intervals. Image contrast was normalised to tunicamycin, 
GFP positive samples. 60 
 
4.2.7  GFP fluorescence in vivo.  
6cm plates were seeded with 50 μl of E. coli OP50 at 0.8A [OD600] and left 24h to settle. Plates 
were treated with either M9 buffer 100ml, Ethanol [250mM] or iso-propanol [250mM] at a plate 
ratio of 4:1:1 respectively. Larval stage 4, pmyo2::GFP (slo-1 neuronal rescue) worms were 
separated 1 day before treatment and incubated 24h at 20°C. L4+1 day worms were transferred 
to M9 plates for 5 min. Images were recorded using a CCD camera mounted to a fluorescent 
microscope after 5 min. Worms were then transferred to test plates of either M9, ethanol or iso-
propanol for 5 min before photographing.  
4.2.8  eGFP fluorescence in vitro.  
EtOH solutions of various concentrations were made by serial dilution in MQ H2O. The 
different solutions of EtOH were added 1:1 to a solution of soluble eGFP (purified from GST-
eGFP diluted in MQ H2O) in a 1.5ml reaction tube. Three 100µl aliquots of this were 
transferred to the wells of a black-walled, clear-bottomed 96-well plate. The plate was read in a 
Tecan-Sapphire fluorescence plate reader using FITC excitation/Emission settings (Ex485, 
Em535, 20nm bandwidth). Each point is the mean of the three wells. The 1st scan (black line) 
was done initially @ 15:56, the other scans were made subsequent to this (@ 16:47, 16:49 and 
16:50 respectively) using the same plate-reader settings after pipetting out the 2nd experiment 
(the plate was not kept in the dark). These were provided by Tom Carter and Matthew Hannah, 
Molecular Neuroendocrinology, Mill Hill. 
4.3  Results 
Ethanol has been shown to be a source of ER stress in both mammals and C. elegans. Unfolded 
protein response was monitored in C. elegans using the feedback mechanism of HSP4/BiP 
induction on ER stress. This was done using a GFP tagged HSP4 protein ER stress increases 
HSP4 protein levels and the level of fluorescence in vivo. This line is an integration of a HSP-4 
promoter that drives expression of GFP upon ER production. Under control conditions the level 
of expression in well fed worms is too low to produce a detectable signal. In contrast growing 
worms on plates laced with tunicamycin shows a rapid and sustained induction of expression. 
These preliminary observations indicate that this reporter can be used to investigate if ER stress 
(see Figure 4.3 for example worms).  
4.3.1  Treatment of worms with ethanol show no induction of an UPR 
Fifty larval stage 4 worms + 1day worms were treated with tunicamycin 30 μg ml
-1 positive 
control
 ethanol 450mM, DMSO vehicle control and no treatment for 24 hours and then 
withdrawn from treatment. Treatment with the N-glycosylation inhibitor Tunicamycin at 30 μg 
ml
-1 activates increased GFP fluorescence compared to the basal levels of no treatment and 
DMSO vehicle controls. Ethanol intoxication showed no detectable increase in fluorescence 61 
 
activate the unfolded protein response above the basal levels of controls at the 6 (Fig 4.3 (A)) 
and 24 h time limits (Fig 4.3 (B)). Ethanol treatment also fails to induce a response on treatment 
withdrawal (Fig 4.3 (C)). Tunicamycin treatment does induce or retain a persistent UPR on 
withdrawal from the pharmacological insult.  
Ethanol intoxication shows a behavioural phenotype (Figure 4.4). This is manifest in the 
withdrawal response when the worms were removed from ethanol and tested in a food race. The 
removal from treatment by ethanol, tunicamycin and controls continue to show a behavioural 
phenotype consistent with expected results when assayed in a food race paradigm. Control 
Worms show 87% and 81% of the population reaching the food after a 2 hour period 
respectively consistent with previous data (see chapter 2). In contrast worms treated with 
ethanol for 24h and then withdrawn show 17% of the population reaching the food reward after 
2 hours. Tunicamycin treated worms also show a deficit in the percentage of the population 
reaching the food when subsequently tested in the food race in the absence of tunicamycin after 
2 hours at 46%.  This is less than control worms but better than the ethanol withdrawn worms. 
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Figure 4.3. zdIs4 (phsp4::GFP) worms after ethanol conditioning at 6 hours, 24 hours and 1 hour post 
treatment withdrawal. 
zdIs4 (phsp4::GFP) worms photographed under 484 nm fluorescent light at 35x magnification. (A) 
Worms at 6 hours after treatment with ethanol 450mM (EtOH), tunicamycin 30 μg ml
-1 (TUN),
 DMSO 
0.01% (DMSO) and no treatment (Control). (B) Worms at 24 hours after treatment with ethanol 
450mM (EtOH), tunicamycin 30 μg ml
-1 (TUN),
 DMSO 0.01% (DMSO) and no treatment (Control). (C) 
Worms at 1 hour 10 min post 24 hour treatment with after treatment with ethanol 450mM (EtOH), 
tunicamycin 30 μg ml
-1 (TUN),
 DMSO 0.01% (DMSO) and no treatment (Control).  
 64 
 









































Control Tunicamycin DMSO Ethanol
 
Figure 4.4. zdIs4 (phsp-4::GFP) worms raced over 5 cm towards a food reward. 
Population reaching food is recorded every 10 min for 2 hours. Worms conditioned for 24 hours and 
withdrawn from treatment of: ethanol 450mM, tunicamycin 30 μg ml
-1, DMSO (0.01%) and no 
treatment (control) before race. 87% untreated worm population, 81% DMSO treated worms, 46% 
tunicamycin treated worms and 17% ethanol treated worms reached the food reward after 2 hours.  
4.3.2  Treatment of worms with ethanol and tunicamycin does not potentiate an 
UPR 
Initial results suggested that the addition of ethanol to C. elegans at 450mM was insufficient to 
trigger an unfolded protein response (Fig 4.3). It was investigated whether ethanol was enough 
to prime a stress response on dual treatment with tunicamycin. It was also investigated whether 
ethanol at higher concentrations than previously used was enough to trigger an unfolded protein 
response.  
20 larval stage 4 + 1 day worms were treated with either ethanol (450mM, 900mM, 1.35M) 
ethanol (450mM)and tunicamycin (5 μg ml
-1) or a DMSO vehicle control, DMSO. The worms 
were investigated for fluorescence after 6 hours (Fig 4.5) and 24 hours (Fig 4.6). Ethanol at 
450mM alone was unable to induce a GFP positive stress response beyond basal levels of 
controls after 6 hours (Fig 4.5 (A)) and 24 hours (Fig 4.6 (A)). Treatment with ethanol and 
tunicamycin showed no increased GFP linked stress response beyond controls at both 6 hours 
(Fig 4.5 (C)) and 24 hours (Fig 4.6 (C)). This suggests that ethanol is unable to potentiate a 
stress response by tunicamycin treatment for 24 hours.  
Treatment of worms with increased ethanol concentrations 900mM and 1.35M showed no HSP-
4 induction at the 6 hour time period (Fig 4.5 (B)). At 24 hours 1.35M ethanol may induce a 
slight increase in GFP and may indicate a low level stress response (Fig 4.6 (B)).  65 
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Figure 4.5. zdIs4 (phsp4::GFP) worms after conditioning for 6 hours with increasing ethanol 
concentrations and dual tunicamycin treatment. 
zdIs4 (phsp4::GFP) worms imaged under 484 nm fluorescent light at 35x magnification. (A) Worms at 6 
hours after treatment with ethanol 450mM (EtOH), tunicamycin 30 μg ml
-1 (TUN),
 DMSO 0.01% 
(DMSO) and no treatment (Control). (B) Worms at 6 hours after treatment with ethanol 450mM 
(EtOH), 900mM (EtOHx2), 1.35M (EtOHx3) and tunicamycin 30 μg ml
-1 (TUN). (C) Worms at 6 hours 
after treatment with ethanol 450mM (EtOH), tunicamycin 5 μg ml
-1 (TUN), ethanol 450mM and 
tunicamycin 5 μg ml
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Figure 4.6. zdIs4 (phsp4::GFP) worms after conditioning for 24 hours with increasing ethanol 
concentrations and dual tunicamycin treatment. 
zdIs4 (phsp4::GFP) worms photographed under 484 nm fluorescent light at 35x magnification. (A) 
Worms at 24 hours after treatment with ethanol 450mM (EtOH), tunicamycin 30 μg ml
-1 (TUN),
 DMSO 
0.01% (DMSO) and no treatment (Control). (B) Worms at 24 hours after treatment with ethanol 
450mM (EtOH), 900mM (EtOHx2), 1.35M (EtOHx3) and tunicamycin 30 μg ml
-1 (TUN). (C) Worms at 24 
hours after treatment with ethanol 450mM (EtOH), tunicamycin 5 μg ml
-1 (TUN), ethanol 450mM and 
tunicamycin 5 μg ml
-1 (EnT), ethanol 450mM and DMSO 0.01% (EnD). These results are representative 
images from three independent experiments with 20 worms per treatment. 69 
 
4.3.3  Investigating the time dependent effects of ethanol treatment on the UPR 
Treatment with ethanol 450mM failed to produce an assayable unfolded protein response at the 
6 hour and 24 hour time points (Fig 4.3). Treatment with ethanol and tunicamycin combined 
also failed to potentiate an unfolded protein response at 6 hours (Fig 4.5) and 24 hours (Fig 4.6). 
It was the investigated whether the UPR is induced on acute ethanol and ethanol and 
tunicamycin combined treatments over a 6 hour period (Fig 4.7).  
L4 +1 worms were treated with ethanol 250mM, tunicamycin 5 μg ml
-1, DMSO vehicle control, 
heat shock (28°C), ethanol 250mM and tunicamycin 5 μg ml
-1, ethanol 250mM and DMSO 
0.01% control and no treatment for 24 hours. Samples were photographed at 1 hour intervals for 
6 hours (Fig 4.7) and then again at 24 hours and 1 hour post treatment withdrawal (Fig 4.8). 
Heat shock was stopped at 6 hours  
Consistent with previous results ethanol showed no induction of GPR and, by extension, the 
UPR at 1 hour intervals for 6 hours, or at 24 hours. In addition there was no induction following 
a 1 hour post withdrawal. Tunicamycin showed an induction of GFP/UPR at 4 hours onwards. 
Ethanol and tunicamycin combined treatment also showed induction at 4 hours onwards and 
was indistinguishable from tunicamycin only treatment. Induction remained constant on 
withdrawal from treatment for both ethanol and tunicamycin and tunicamycin only samples. 
Heat shock treatment induced the UPR from the 2 hour time point until the 6 hour as indicated 
by the relative increase in the organism’s fluorescence. After removal from the heat shock the 
increased florescence had dissipated by the 24 hour time point. An induction of the UPR by heat 
shock treatment confirms that the strain is not specific for tunicamycin treatment only and that 
ethanol fails to induce an unfolded protein response and potentiate ER stress induced by 
tunicamycin. 
Withdrawal from treatment induces a behavioural response in worms (Fig 4.9). 68% worms 
receiving no treatment (control) reached the food reward after 2 hours. Tunicamycin, DMSO 
and heat shock treated worms had slightly less of the population reaching the food reward at 
51%, 54% and 54% respectively. This is in contrast to ethanol treated worms which only 7% of 
the population reached the food after 2 hours. Ethanol and DMSO combined treated worms had 
4% of the population reach the food similar to ethanol only treatment. Worms treated with 
ethanol and tunicamycin treatment had no worms make the food reward after 2 hours which 
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Figure 4.7. zdIs4 (phsp4::GFP) worms at 1 hour intervals for 6 hours with ethanol and dual tunicamycin 
treatment. 
zdIs4 (phsp4::GFP) worms photographed under 484 nm fluorescent light at 35x magnification. Worms 
treated with ethanol 250mM (EtOH), tunicamycin 5 μg ml
-1 (Tun),
 DMSO 0.01% (DMSO), ethanol 
250mM and tunicamycin 5 μg ml
-1 (EnT), ethanol 250mM and DMSO 0.01% (EnD), heat shock 28°C 
(28°C) and no treatment (Con) for 6 hours. Samples analysed every 1 hour for 6 hours representative 
photos shown in rows from left to right (1h, 2h, 3h, 4h, 5h and 6h). Representative of 2 independent 









































       
 
Figure 4.8. zdIs4 (phsp4::GFP) worms conditioned with ethanol and dual tunicamycin treatment for 24 
hours and 1 hour post treatment withdrawal. 
zdIs4 (phsp4::GFP) worms photographed under 484 nm fluorescent light at 35x magnification. Worms 
treated with ethanol 250mM (EtOH), tunicamycin 5 μg ml
-1 (Tun),
 DMSO 0.01% (DMSO), ethanol 
250mM and tunicamycin 5 μg ml
-1 (EnT), ethanol 250mM and DMSO 0.01% (EnD), heat shock 28°C 
(28°C) and no treatment (Con) for 24 hours (24) and withdrawal, 1 hour after 24 hour treatment 
(With). 72 
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Figure 4.9. Food race of zdIs4 worms after 24 hours ethanol conditioning. 
zdIs4 (phsp-4::GFP) worms raced over 5 cm towards a food reward. Population reaching food is 
recorded every 10 min for 2 hours. Worms conditioned for 24 hours and withdrawn from treatment 
of: ethanol 250mM (EtOH), tunicamycin 5 μg ml
-1 (tunicamycin),
 DMSO 0.01% (dmso), ethanol 250mM 
and tunicamycin 5 μg ml
-1 (EtOH + Tun), ethanol 250mM and DMSO 0.01% (EtOH + DMSO), 6 hours 
heat shock 28°C (HeatShock) and no treatment (control). 68% of the control worm population made 
the food reward after 2 hours. 51% tunicamycin, 54% DMSO and 54% heat shock treated worm 
populations made the food. Ethanol treated worms had 7% of the population reach the food. Ethanol 
and DMSO treated worms had 4% of the population reach the food and ethanol and tunicamycin 
treatment had no worms make the food reward after 2 hours. 
 
4.3.4  Investigating the quenching of GFP by ethanol 
The results from the zdIs4 (phsp-4::GFP) suggest that ethanol does not play a role in triggering 
the unfolded protein response in C. elegans in behaviourally relevant treatments. It also plays no 
role in potentiating an UPR response to tunicamycin treatment. These results may have been 
due to a role of ethanol in changing the fluorescence of GFP through altered protein 
conformation or misfolding, masking a positive result. Previous literature has highlighted 
problems using a GFP reporter construct similar to the zdIs4 strains and suggested that ethanol 
may interfere with the protein. To investigate the likelihood of false negative results the 
fluorescence of pmyo2::GFP tagged C. elegans were compared under ethanol and non-ethanol 
conditions. Worm strains used were neuronal rescue slo-1 mutants in the reporter background. 
slo-1 should not alter GFP fluorescence, and ethanol has not been reported to alter expression of 
the GFP construct array. The pmyo2::GFP array is expressed solely in the pharynx of C. 
elegans.  73 
 
larval stage 4 + 1 day worms were treated with M9 saline buffer control, 240mM ethanol or iso-
propanol  for  5  min  after transfer  from  5  min  incubation  in  M9  saline  buffer.  Iso-propanol 
controls  were  included  as  an  indicator  of  solvent  effect  on  fluorescence.  Samples  were 
photographed before and after transfer to detect obvious changes in GFP fluorescence  (Fig 
4.10). The experiment was repeated twice under different cameras, hence the change in colour. 
No obvious change in fluorescence can be detected between the samples in any of the three 
treatment conditions.  
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Figure 4.10. Visual comparison of GFP expressing worms before  and after ethanol and iso-propanol 
treatment. 
pmyo2::GFP worms photographed under 484 nm fluorescent light at 35x magnification. Two sets of 
worm groups were treated with either M9 control (M9), 240mM ethanol (EtOH) or iso-propanol 
(PrOH) for 5 min after 5 min incubation in M9 buffer. Worms after 5 min M9 (BEFORE) and 5 min 
treatment (AFTER) photographed.  No difference is observed in fluorescence on control, ethanol or 
iso-propanol treatment. Repeated experiments differ in camera type only.   
 
4.3.4.1  In vitro GFP quenching by ethanol 
An investigation into the changing fluorescence of eGFP in vitro on increasing ethanol 
concentrations was carried out by the team at Mill Hill (unpublished, Personal correspondence). 
Increasing concentrations of ethanol made by serial dilution were mixed 1:1 with eGFP and 
sampled three times. Samples were read from a black-walled, clear bottomed 96 well plate and 
read with a Tecan-Sapphire fluorescence plate reader (Fig 4.11). 
Initial ethanol concentrations reduce the fluorescence of eGFP by approximately 10-20% until 
recovery at ~250mM. Fluorescence then increases progressively by approximately 70% to 
100% on ethanol concentrations up to 2.8M. The difference between scan results is likely due to 
photo bleaching between scan runs. The 1st scan was done initially at 15:56, whilst the other 




Figure 4.11. Fluorescence of eGFP on increasing concentrations of ethanol as read by a Tecan-Sapphire 
fluorescence plate reader. 
Each point is the mean of three samples. Ethanol concentrations below 250mM cause a slight 
reduction on fluorescence by 10-20%, with a progressive increase in fluorescence of ~70-100% up to 
2.8M ethanol. Difference between scans is likely photo bleaching between scan run times. Ethanol 
alone gives no fluorescence under the same settings.  
4.3.5  Behavioural responses to ethanol in hsp-4
-/- worms 
Initial investigation shows that hsp-4 is not induced on ethanol treatment and it is unlikely that 
the UPR mediates ethanol withdrawn behavioural phenotype. To confirm the role of the UPR 
marker HSP4 in ethanol mediated behaviour gk514 worms, which possess a mutant inactive 
copy of the hsp-4 gene, were investigated for effect on ethanol response phenotypes. Initial 
results suggest that hsp-4 mutants do not show any difference in ethanol mediated behaviour 
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Figure 4.12. Food race of gk514 and N2 worms on 50mM ethanol, 300mM ethanol and ethanol 
withdrawal. 
gk514 hsp-4
-/- and N2 worms raced over 5 cm towards a food reward. Population reaching food is 
recorded every 10 min for 2 hours. gk514 (GK) and N2 (N2) worms treated with either ethanol 50mM 
(Low), 300mM ethanol (High), or conditioned for 6 hours prior to race with 300mM ethanol and raced 
on no ethanol (Withdrawn) or with no treatment (Control). Each point is the mean of 6 repeats ±SE.  
4.4  Discussion 
The unfolded protein response is an adaptive mechanism for coping with cellular stress. Its wide 
acting, plastic response is implicated in the pathology of several diseases. The implication of 
whether the UPR is a consequence or a cause of disease is still to be elucidated. It has been 
implicated in the underlying problems associated with chronic ethanol consumption, particularly 
in hepatic steatosis and the development of fatty liver disease. The down regulation of 
methionine synthase by ethanol is believed to be a trigger for a condition known as 
hyperhomocysteinemia. Hyperhomocysteinemia has been shown to be a trigger for the unfolded 
protein response and can lead to a number of conditions including atherosclerosis. Whilst the 
link between chronic ethanol use and the UPR is being forged, little is known about whether the 
unfolded protein response is an initial cellular response to ethanol stress. Whilst several 
components of the UPR have been shown to be transcriptionally upregulated on ethanol 
treatment, a direct link between acute ethanol response and the UPR is still contentious. The 
model organism C. elegans has been used to dissect the roles of both ethanol treatment and 76 
 
separately the UPR. It has been shown that treatment with ethanol at 7%, enough to cause 
complete paralysis of the worm and LD50 on withdrawal, can trigger the UPR. More subtle, 
behavioural phenotypes can be observed on ethanol treatment in the worm at lower 
concentrations such as intoxication, withdrawal, relief from withdrawal and tolerance. The 
molecular mechanism underpinning these behaviours is of importance in both medical and 
neurological research. If ethanol stress can trigger an unfolded protein response in C. elegans 
then the molecular mechanism may underpin aspects of these the behavioural phenotypes. Much 
of this is likely to arise through homeostatic plasticity which in turn involves molecular 
remodelling of the nervous system. In several models of synaptic plasticity the processing of 
neuronal receptors is important and events at the level of the ER appear salient. This reinforces 
the potential for the ER stress to underpin functional and dysfunctional plasticity associated 
with adaptive states including those that arise in response to ethanol and other addictive drugs. 
4.4.1  Ethanol treatment fails to elicit an hsp4::GFP response in C. elegans  
Evidence from treatment of C. elegans suggests that the unfolded protein response is not 
triggered by treatment with ethanol at behaviourally relevant concentrations.  Treatment with 
ethanol at 450mM for 24 hours failed to induce an hsp-4 promoter driven GFP positive response 
when compared to controls. Withdrawal from ethanol also did not induce a phsp-4::GFP 
response. Withdrawal after 24 hours still elicited a behavioural response as measured by the 
food race assay. Only 17% of ethanol withdrawn worms made it to a food reward after 2 hours 
in comparison to 87% and 81% of the population in negative controls. Interestingly worms 
treated with an insult of tunicamycin at 30 µg ml
-1, which did trigger an unfolded protein 
response, also produced a behavioural response. Only 46% of tunicamycin withdrawn worms 
made it to the food reward after 2 hours, a larger number than the ethanol withdrawn worms. 
The deficit in locomotion of the tunicamycin withdrawn worms may be a result of the unfolded 
protein response, which was still activated post treatment. Ethanol withdrawn worms which did 
not induce an UPR, showed an inability to commute towards the food reward to a greater degree 
than tunicamycin withdrawn worms. This suggests that the UPR does not play a role in ethanol 
withdrawal mediated behaviour. 
Ethanol does not potentiate a stress response to tunicamycin treatment. Worms treated with 
450mM ethanol and tunicamycin 5 µg ml
-1 show no increased stress response at 6 and 24 hours 
when compared to separate tunicamycin 5 µg ml
-1 treatment. If ethanol induced a stress 
response that was at a level too low to detect with the phsp-4::GFP array or worked in a stress 
pathway independent of hsp-4 induction, then ethanol treatment might be expected to prime a 
tunicamycin response. Comparison with tunicamycin 5 µg ml
-1 control showed no increased 
fluorescence suggesting that it is unlikely that 450mM ethanol induces a UPR. This is also 
repeated in the solo 450mM ethanol treatment. Ethanol treatment at higher concentrations for a 
duration of 24 hours may have induced a small phsp-4::GFP response. 1.35M ethanol shows a 77 
 
slight increase in fluorescence beyond control samples at the 24 hour time point. This ethanol 
concentration is approaching the reported level used to induce an UPR in C. elegans (Kwon et 
al., 2004; Uccelletti et al., 2004). Caution is noted as the concentrations of ethanol used were 
not experimentally verified in this experiment.  
The unfolded protein response is not triggered over a 6 hour time course on 250mM ethanol 
treatment and does not potentiate a UPR in tunicamycin stressed worms. Investigating whether 
an initial early stress response is induced which is missed at the 6 hour time point; treatments 
were monitored every 1 hour for 6 hours, then again at 24 hours and 1 hour post withdrawal. 
Ethanol fails to induce a UPR over 24 hours and at early time points.  
 
4.4.2  Ethanol fails to potentiate an hsp4::GFP response in C. elegans 
Adding weight to earlier results 250mM ethanol also fails to potentiate an UPR to tunicamycin 
induced stress at early, 1-6 h and late, 24 h, time points. Tunicamycin treatment activated the 
UPR at 4 hours which was similarly seen in ethanol and tunicamycin treatment with no 
difference in the level of response. Ethanol and ethanol and tunicamycin treatment combined 
also fail to induce and to prime a stress response on treatment withdrawal. Induction of the UPR 
may have been tunicamycin specific. 6 hours heat shock at 28°C induced a stress response from 
2 hours up until 6 hour point of treatment withdrawal. The UPR failed to persist in the heat 
shocked worms up to the 24 hour time point. Result indicates that phsp-4::GFP response is not 
tunicamycin specific. Worms withdrawn from treatment were assessed in a food race assay. 
68% worms receiving no treatment reached the food reward after 2 hours. Tunicamycin, DMSO 
and heat shock treated worms had slightly less of the population reaching the food reward at 
51%, 54% and 54% respectively. This is in contrast to ethanol treated worms which only 7% of 
the population reached the food. Ethanol and DMSO combined treated worms had 4% of the 
population reach the food, similar to ethanol only treatment. Worms treated with ethanol and 
tunicamycin treatment had no worms make the food reward after 2 hours.  
Worms in this assay had lower population numbers make the food reward after the 2 hours than 
previous race assay. This is likely due to the increased starting population size of the initial 
assay. Of the 150 worms for each treatment, the mean starting the race was 97 worms, a transfer 
efficiency of 65%. For the second assay 60 worms averaged a total population size of 40, 66% 
transfer efficiency. The large numbers of worms increases the worm density at a single spot 
beginning each race. Worms react by a backwards motion and omega turn in response to body 
touch. Increasing the worm density at a specific place may increase the time spent in a 
locomotory response to repel away from the population spot beginning the race. This suggests 
caution when comparing the two assays. We do see a similar range of phenotypes between the 
two data sets; with tunicamycin withdrawn worms having a larger population reaching the food 78 
 
after 2 hours than the ethanol treated worms. Again the UPR is still active in tunicamycin 
treated worms compared to inactive in ethanol withdrawn worms. Worms treated with both 
ethanol and tunicamycin combined did not reach the food reward at all. Whilst the result 
suggests that the use of the two insults is additive, more repeats is needed to confirm that the 
results differ significantly and are not due to random variation. If ethanol withdrawn behaviour 
shares a common molecular pathway with tunicamycin withdrawn worms then dual insult 
would be expected to behaviourally redundant and show the same level of incapacitation as 
ethanol treatment. If the results are additive however it would suggest a separate molecular 
pathway underscoring the behavioural phenotypes.  
4.4.3  GFP fluorescence is unlikely affected by ethanol presence 
The treatment of ethanol on phsp-4::GFP worms fails to induce an increase in fluorescence and 
indicate an unfolded protein response. Treatment of ethanol may induce a response but remain 
undetected due to quenching of the fluorophore. Using worms that express GFP independently 
of ethanol treatment it was investigated whether ethanol could cause a change in fluorescence 
that would lead to a depression of a GFP mediated response. Using myo2 promoter GFP is 
expressed solely in the pharynx of worms. A change in conditions from control buffer to ethanol 
treatment would reveal if ethanol had any quenching effect on GFP in vivo. Include was an iso-
propanol control to counter for any change in solution properties which may affect fluorescence. 
Worms treated with 240mM ethanol did not show any obvious difference in fluorescence 
output. This suggests that ethanol does not play a role in GFP quenching and that the results 
from UPR assays are not the result of false negatives. The quenching of GFP was also 
confirmed using in vitro GFP fluorescence. Using a fluorescent plate reader on GFP increasing 
concentrations of ethanol were tested for the effect on fluorescence. Initially ethanol decreases 
GFP slightly up to 100mM which increases to normal levels on 200mM ethanol. The results 
picked up by the UPR assays are unlikely to be quenched by ethanol and help confirm that the 
results are not false negatives. Beyond 200mM GFP fluorescence increases on treatment with 
molar concentrations of ethanol. This suggests that the increase in fluorescence that was seen on 
worms treated with 1.35M ethanol may be a false positive. Quantification of all samples is 
needed to determine whether the link between in vitro and in vivo ethanol on GFP is constant.  
Investigating the link between the UPR and ethanol mediated behaviour was also looked at the 
role of HSP-4 on ethanol intoxication. Preliminary data also suggests that the UPR does not 
play a role in ethanol mediated behavioural responses. Worm race assays on gk514 hsp-4
-/- 
shows no difference in response to low levels of ethanol than that of matched paired controls. 
Work is currently ongoing to elucidate the role that the UPR sensor hsp-4 plays in ethanol 
mediated behaviour.   
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The investigation has shown that the induction of a stress response by ethanol is unlikely and 
that the UPR does not underlie the behavioural phenotypes seen on ethanol treatment. Ethanol 
fails to induce a phsp-4::GFP response at 250mM and 450mM when conditioned for 24 hours 
and on withdrawal. Ethanol also fails to potentiate a stress response induced by tunicamycin 
treatment under the same conditions. The lack of an UPR is likely due to ethanol not triggering 
ER stress rather than quenching of the reporter GFP. Ethanol withdrawal fails to induce an UPR 
and exhibits a behaviour resulting in locomotory deficit in food race paradigm. Tunicamycin 
sustains an UPR on treatment withdrawal and exhibits a less pronounced depression in 
locomotory function. Preliminary results from gk514 hsp-4
-/- show no difference in behavioural 
phenotype on low ethanol doses. These results suggest that the UPR is unlikely to regulate 
behavioural responses seen on ethanol treatment.  
The use of the pshp-4::GFP to monitor UPR induction is a widely used and validated reporter 
system. The results from the UPR assays show clear positive responses from the tunicamycin 
treated control samples. The negative controls also show a clear stable level of basal GFP with 
definitive contrast to an induced response. Whilst clear that ethanol does not induce a response 
to a similar degree as tunicamycin, and that this is not specific to pharmacological insult but to 
ER stress, samples need to be quantified in a defined region of interest for fluorescence 
intensity. This would help confirm that ethanol plays no role in triggering an UPR. It can also 
confirm the link between GFP fluorescence in vitro and in vivo on ethanol treatment. If the in 
vitro samples show an increase in fluorescence in ethanol conditions that show an in vivo 
positive response, this may be attributed to ethanol’s effect on the fluorophore, rather than an 
activation of an UPR.  
Whilst the phsp-4::GFP array is integrated into all cells the UPR response does show increased 
reporter activity in the endothelial cells of the gut. Endothelial cells are responsible for 
producing high numbers of secretory proteins and are predominantly affected on ER stress. 
Whilst able to monitor global UPR induction, an indication of cell type specific UPR induction, 
such as in neurons, is limited. This is partially covered by investigating the behavioural 
phenotype of UPR component mutants, in which all cells have a mutant copy.  
C. elegans possess a paralog of hsp-4 with 98% identity, hsp-3. HSP3 is believed to play a 
redundant role in sensing the UPR but diverges in its role in development (Sasagawa et al., 
2007). It is unclear how the presence of hsp-3 affects the reporter construct and the ability to 
sense low levels of ER stress. As both of the proteins converge through ER sensors and 
transcription factors to up regulate hsp-4 it is unlikely that the reporting of the UPR is 
compromised. HSP3 may pose problems in trying to use gk514 hsp-4 
-/- worms as its function is 
likely to be redundant. Double mutants are reported to be embryonic lethal and are essential for 
development. Over expression of hsp-4 and RNAi of hsp-3 in an hsp-4 background may provide 
a better insight into the role HSP4 plays in ethanol behaviours.  80 
 
The results of these experiments suggest that ethanol is not acting as an ER stressor directly or 
with tunicamycin treatment. Previous literature has reported that transcriptional upregulation of 
UPR elements is observed under ethanol treatment and that chronic ethanol use in mammals 
triggers the UPR with pathological outcomes. Ethanol concentrations that are lethal to 50% of C 
.elegans in experiments have been shown to trigger the UPR. Whilst these findings suggest that 
such a high concentration may trigger an UPR, they also may be affected by ethanol on the level 
of fluorescence detected. This needs to be further validated in vivo before extrapolating to other 
work.  
Work in cell lines suggests that whilst UPR markers might be transcriptionally upregulated this 
does not translate to a proteomic response on acute ethanol exposure. Higher concentrations of 
ethanol and chronic ethanol treatment have shown to induce a protein based UPR response 
suggesting that the UPR may lie in the extremes of ethanol conditioning. Using C. elegans we 
failed to see a HSP4 driven UPR on ethanol treatment which causes behavioural responses. It 
may be that whilst ethanol may up regulate UPR transcripts, this is not seen at the translational 
level. If this is replicated in C. elegans it may represent a novel mechanism for translational 
control or a mechanism of action for ethanol. eIF2ʱ controls general translation repression and 
selective translation of UPR transcripts. It is tempting to hypothesise that ethanol may modulate 
activation of eIF2ʱ. 
 
4.5  Future work 
The results presented here although clear need further evaluation to confirm beyond doubt. 
Levels of fluorescence need to be quantified and evaluated to ensure a high level of certainty 
that ethanol does not trigger a low level phsp-4::GFP response. The link between high 
concentrations of ethanol that have been reported in the literature and an increase in eGFP 
fluorescence on increasing ethanol concentration in vitro could also be verified. RNAi 
knockdown of hsp-3 in a gk514 hsp-4
-/- background and its role in ethanol mediated behaviour 
could also confirm the lack of an UPR role in behavioural phenotypes. This could also be 
investigated with dual tunicamycin ethanol treatment withdrawal on locomotion. An additive 
depression on locomotion would suggest separate pathways whilst a redundant response would 
point to a common, downstream pathway. The xbp-1/ire-1 pathways have been shown to control 
around 80% of UPR transcripts including hsp-4 induction. Investigation of the behavioural 
effects of ethanol on this pathway would also be good confirmation of a role for the UPR. 
Several reports have highlighted a number of transcripts upregulated by ethanol that 
corresponds to an induction of the UPR. Evidence that the UPR is not activated at the 
transcription level by ethanol could further validate this work. If ethanol does modulate UPR 81 
 
mediated transcription then a proteomic analysis would shed light on why the response is not 
seen in phsp-4::GFP worms and may indicate potential sites of action for ethanol.  
 82 
 
5  Discussion 
Ethanol mediated behaviour can be modelled in the organism C. elegans. The behavioural 
phenotypes displayed by the worms reflect the conditioning paradigm, ethanol concentration 
and exposure time; simply paralleling the behaviours of other organisms. Although not directly 
analogous to the complex behaviours of human-ethanol interaction, C. elegans demonstrates the 
basic depression with increased exposure time or dosage treatment, and subsequent 
improvement on treatment cessation. Other more subtle behaviours of relief from withdrawal 
and tolerance have been shown elsewhere. It is possible too that the effects of a lower 
concentration of ethanol treatment have been touched upon by this study, although results 
warrant further investigation. 
It is clear from this study that relatively high concentrations of ethanol are enough to depress 
activity in both locomotory output and pharyngeal pumping. This depression of activity is 
limited to 300mM ethanol treatment with an exposure time of 6 hours. Lower concentrations of 
ethanol fail to elicit a clear response in either locomotory or pharyngeal measures. Worms show 
a clear recovery from ethanol exposure as measured by locomotion, showing an increased but 
not fully recovered ability for a population to taxi towards a food stimulus. The withdrawal 
behaviour is, in part, governed by a change in bend type and turn frequency, shown elsewhere. 
This behaviour is more efficient at allowing worms to chemotax than the depressed, shallow 
movements of the 300mM ethanol intoxicated worms. 
Although the effects are pronounced with higher concentrations of ethanol, the picture is far less 
clear with decreasing ethanol concentration. Investigating how ethanol concentration effects 
pharyngeal pumping, an interesting observation was noted. The worm’s initial reaction to the 
presence of the food stimulus is affected by the presence of ethanol. Worms exposed to ethanol 
will move from a food rich area to a food sparse area. Experiments were adjusted to control for 
the presence or absence of food; as there is a higher pharyngeal pumping rate when food is 
present and movement off food may have affected results. Depression of pharyngeal activity on 
exposure to 300mM ethanol remains independent of food availability, as does the lack of effect 
at lower ethanol concentrations (<300mM). On both food present and food absent test 
environments, higher ethanol concentrations depress pharyngeal pumping, whereas lower 
ethanol concentrations have no significant affect. 
Environment preference does change with ethanol concentration, with worms exposed to 
increasing concentrations of ethanol moving from food-present to food-absent areas. Lower 
concentrations of ethanol, down to 25mM, are still enough to stimulate this behaviour. Either a 
secondary interaction of ethanol with the environment is being sensed by the worms or a direct 
behavioural change as a result of ethanol is causing this phenotype. Preliminary experiments 83 
 
controlling for bacteria-ethanol interaction point to a possible effect on the worms rather than a 
change in the food environment. Heat-killed bacterial food, and bacteria transferred from 
exposed and non-exposed environments suggest that there is little change in the bacteria that is 
sensed by the worms on ethanol exposure. More work is needed to unravel the complexity of 
this phenotype. 
Whilst the worm race assay provides a foundation for studying the distinct ‘states’ that arise 
with worm intoxication and conditioning, it is unable to pick up more subtle phenotypes that 
arise outside the spectrum of gross movement changes that perturb  locomotion. The 2 hour 
experimental time fails to account for changes within that spectrum and initial changes that 
occur on ethanol intoxication. The race assay provides a useful tool for characterising the 
mechanisms behind locomotory and chemotaxis behaviour affected by ethanol, but is unable to 
provide a platform for identifying behavioural changes on lower ethanol intoxication. The 
pharyngeal pumping rate offers a new angle to explore that can move away from movement and 
co-ordination behaviour. It also has the advantage of being able to explore more direct 
measurements of a simplified, yet still complex, neuronal network at the cellular level and relate 
this back to pharyngeal behaviour. It is unfortunate that initial experiments failed to show any 
correlation between behavioural change and sub 300mM ethanol treatments, although 
experiments off food hint at future possibilities. 
Whilst pharyngeal pumping was unable to show a distinct clear phenotype on low ethanol 
intoxication, it did lead to the observation of environmental dispersal in ethanol treated worms. 
This observation was able to show worms respond to an ethanol environment by either 
increased movement, at least initially, or an aversion/attraction behaviour. The role of the 
bacterial lawn is unclear, but initial experiments at least suggest that dispersal is a response to 
the ethanol. The mechanism behind this phenotype may help understand mechanisms of low 
dose ethanol intoxication. 
All of the phenotypes studied in C.elegans provide a useful and descriptive insight in to worm-
ethanol interaction. It is through the use of these techniques that the basic mechanisms of 
ethanol interaction can be dissected to shed light on the molecular basis of behaviour.  
5.1  Bioinformatic identification of genes involved in ethanol 
response 
Given the number of studies that show the many ways in which ethanol interacts to control 
behaviour, and yet the specificities of a distinct pathway still elude researchers after many years 
of study, it is unsurprising that the database of these molecules is enormous and eclectic. The 
current collection of information harvested from papers between 2006 and 2009 on 5 organisms 
contains over 3500 entries on 900 biologically important proteins and molecules. As it stands, 
the database is a work in progress; the information still needs to be analysed and mined for 84 
 
specific trends and correlates. There is also scope for the addition of more information and data 
from other projects. As it stands there is no clear conclusive evidence of one particular pathway 
contributing to ethanol mediated behaviour, but without proper analysis the question is still 
open.  
The difficulty in managing an information source of this size in part comes from two important 
facets; when mining data from one source to another the transition of data without adding or 
losing information, but manipulating the data in such a way that it can be easily used as a 
resource. The other is the process of manually finding and integrating the data out of the 
original sources, the slowest and rate determining step in the construction of the database. The 
first was controlled by the use of an ontological vocabulary. The second by due diligence. 
An ontology is a system of controlled terms each with a predefined meaning that may have a 
hierarchical structure of parent and child terms each with a broader or more specific scope of 
meaning respectively. By controlling the vocabulary to scientifically defined terms and 
structures there was an automatic control over how words were interpreted and more 
importantly loss of data fidelity. The use of a hierarchical vocabulary also has the added bonus 
of aiding future manipulation and mining of data.  
The current database will need to be properly analysed for any possible evidence of linkage 
between ethanol treatment and behavioural outcomes. One of the difficulties that arise from this 
task is the interpretation of the data fields. Each field within the database is a line of evidence 
specifically from a referenced and recorded paper. Whilst this evidence may be data that the 
paper has presented first hand, it may be a reference of other work in the field. Papers tend to 
reference similar papers to their field of study so many of the entries within the database will be 
redundant lines of evidence referencing the same experiments. There must, when analysing 
trends, be some consideration given to reported bias. A simple choice would be to weigh the 
evidence fields with respect to the number of papers cited in the original document, in order to 
counterbalance this problem. 
While the database provides an excellent source of material to direct future experiments, it 
requires a substantial effort to complete and refine to ensure clear evidence can be sourced from 
it to pursue and support future hypothesis. 
5.2  The unfolded protein response and ethanol 
The induction of a stress response by ethanol in Caenorhabditis elegans is unlikely to result in a 
UPR that underlies the behavioural phenotypes seen. A phsp-4::GFP response used as a marker 
to indicate unfolded protein stress pathways did not show any evidence of induction on ethanol 
treatment. This response was absent over a range of ethanol concentrations and treatment time 
points, as well as on treatment withdrawal. Worms treated with ethanol for a protein stress 85 
 
response behaved as expected when challenged with a food race paradigm; confirming that 
whilst the UPR is not elicited by ethanol, the behavioural response is still present. 
Worms treated with tunicamycin, a chemical that disrupts protein folding, did respond 
positively showing an induction of the UPR marker phsp-4::GFP. Worms co-treated with both 
tunicamycin and ethanol failed to induce a response beyond that of tunicamycin alone, 
suggesting that ethanol is unlikely to potentiate a protein stress response. To ensure that the 
phsp-4::GFP marker responds to other initiators of protein stress, worms were also heat 
shocked. Heat shocked worms did show an induction of the phsp-4::GFP marker all be it with a 
quicker response time. To ensure ethanol was not interfering with the phsp-4::GFP marker and 
quenching the fluorescence of the GFP, both in vivo and in vitro experiments were used to show 
there is no change in overall fluorescence. GFP tagged worms were treated with photographed 
before and after ethanol treatment and compared for gross changes in fluorescent output. In 
addition eGFP fluorescence was measured in vitro on increasing ethanol concentrations using a 
Tecan-Sapphire fluorescent plate reader. Both experiments showed no noticeable change in GFP 
fluorescence for the range of concentrations used in the protein stress response assays. 
The pshp-4::GFP assay is a widely used and validated system used to monitor UPR induction. 
The positive induction of a protein stress response and the basal levels of a response absence are 
in clear dichotomy; allowing for a definitive contrast between treatment states. It is clear on a 
whole worm level that ethanol fails to induce a protein stress response, and it is not confounded 
by concentration time or intensity. Whilst the binary nature of the experiments suggest a lack of 
a response on ethanol treatment alone, a region of interest (ROI) intensity computation analysis 
of fluorescence would further support the case for the lack of a potentiated response when co-
treating with ethanol and tunicamycin. An analysis on specific cell types could also help detail a 
clearer picture of ethanol response in neuronal tissues, as whole worm responses are dominated 
by the secretory cells of the gut endothelium which show clearer responses because of their 
higher protein throughput. 
Worms mutant for the UPR response protein HSP-4 showed no significant difference in 
behavioural response to ethanol. Behaviours consistent with ethanol intoxication and 
withdrawal in non-mutant worms were observed in the race assays used.While HSP-4 mutant 
worms show no difference in ethanol mediated behaviour, it is worth noting that C. elegans do 
possess a paralog of hsp-4 with 98% identity, hsp-3. HSP3 is believed to play a redundant role 
in sensing the UPR but diverges in its role in development. It is unclear how the presence of 
hsp-3 affects the reporter construct and the ability to sense low levels of ER stress. As both 
proteins converge through ER sensors and transcription factors to up regulate hsp-4 it is unlikely 
that the pshp-4::GFP assay is compromised. HSP3 may pose problems in trying to use gk514 
hsp-4 
-/- worms as its function is likely to be redundant. Double mutants are reported to be 
embryonic lethal and are essential for development. Over expression of hsp-4 and RNAi of hsp-86 
 
3 in an hsp-4 background may provide a better insight into the role HSP4 plays in ethanol 
behaviours.  
Overall it appears that ethanol does not play a role in triggering or potentiating an unfolded 
protein stress response. Several experiments show that ethanol does not itself trigger a UPR, and 
an UPR is not needed for ethanol mediated behaviour. In addition the molecular controls for the 
UPR are not needed for ethanol mediated behaviour. 
5.3  Conclusions 
C. elegans provides a useful tool for studying the different aspects of ethanol intoxication and 
ethanol mediated behaviour. It provides a platform in which to understand how the different 
paradigms of ethanol conditioning influence behaviour and in turn how this behaviour is 
controlled. This investigation has showed how C. elegans can be used to study the different 
conditioning paradigms of ethanol treatment and that there is still further scope for investigation 
into the controls underpinning ethanol behaviour. 
Documentation of key molecules underpinning the ethanol response from across several species 
should provide a background for further investigation in C. elegans. Whilst incomplete, the vast 
amount of data collected in the database should provide an essential, complementary lead on 
behavioural mechanisms controlling both worm and ethanol behaviour. Analysis and further 
information integration will only add to and aide an essential resource for future studies. 
Documentation of the limitations of the database should allow for relevant trends to be filtered 
accordingly and for any future restructuring and cleaning of the data.  
Whilst several lines of evidence may point to a possible link between mechanism across species, 
conservation is not always guaranteed. Resources such as the ethanol database hope to eliminate 
potential false leads with future analysis. The UPR was a mechanism that had been linked to 
ethanol treatment, but failed to show any signs of response to ethanol or involvement in ethanol 
behaviour. The investigation showed no link between protein stress and ethanol treatment. 
Future database analysis will hopefully lead to similar clear results on both responsive and non-
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